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Abstract 
 
We previously identified the chemical modification S-(2-succino)cysteine (2SC), 
which is formed when the Krebs cycle metabolite fumarate reacts with protein cysteine 
residues, also termed protein succination. Protein succination is increased in the 
adipose tissue of ob/ob and db/db mice in vivo and in 3T3-L1 adipocytes grown in high 
glucose in vitro. The increase in 2SC in the 3T3-L1 adipocyte occurs as a direct result of 
glucotoxicity and increased mitochondrial stress. We have shown that uncoupling 
agents, which lower mitochondrial stress, prevent the increase in succinated proteins. 
 In this study we examined the relationship between increased succination and 
mitochondrial bioenergetics in adipocytes matured in 30 mM (high) vs. 5 mM (normal) 
glucose. In addition we examined if sodium phenylbutyrate (PBA), which lowers protein 
succination, might be acting as an uncoupling agent in adipocytes cultured in high 
glucose. We observed that adipocytes matured in high glucose had a decreased spare 
respiratory capacity, increased proton leak across the inner membrane and increased 
non-mitochondrial respiration, consistent with increased mitochondrial stress. We also 
determined that PBA was not acting as an uncoupling agent but instead appeared to 
lower the mitochondrial respiratory protein content, thereby reducing respiration and 
protein succination.   
 The unfolded protein response (UPR) and endoplasmic reticulum (ER) stress have 
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previously been documented in the adipose tissue during diabetes and during adipocyte 
maturation in high glucose. We assessed the development of ER stress in adipocytes 
matured in 5 mM vs. 30 mM glucose and observed that although most ER stress markers 
were unchanged with glucose concentration, the terminal ER stress marker CHOP was 
consistently elevated in high glucose and this occurred in parallel with increased 2SC. 
 The use of PBA as a therapeutic agent for the treatment of T2DM is currently 
being investigated in human subjects as it has been shown to reduce ER stress in the 
adipose tissue of animal models of T2DM. We examined the effects of PBA 
administration for 8 weeks in db/db mice. We observed reduced serum glucose and 
reduced triglyceride (TG) levels after PBA treatment; however, there was no effect of 
PBA on 2SC or ER stress markers in the adipose tissue of db/db mice. Unexpectedly, PBA 
treatment increased ER stress and TG deposition in the liver of db/db mice.  
Considering that 2SC is an irreversible and stable protein modification we 
wanted to determine if succinated proteins could be degraded intracellularly. We 
demonstrated that succinated proteins are degraded by the lysosome and are released 
from the cell as a free amino acid (2SC) and bound in a peptide.  
Overall, these studies have further extended our knowledge of the relationship 
between mitochondrial stress, protein succination and ER stress. In addition, we have 
determined the mechanism of turnover of succinated proteins in the adipocyte in vitro.
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Chapter I 
General Introduction 
1.1. Epidemiology of Type 2 Diabetes Mellitus 
Diabetes affects 25.8 million people, or 8.3% of the population, and is the 
seventh leading cause of death in the United States. There are 18.8 million diagnosed 
and 7.0 million undiagnosed people with diabetes. From 2005-2008, it was estimated 
that 79 million Americans had prediabetes, based on fasting blood glucose (FBG) and 
hemoglobin A1c levels. Diabetes predominantly affects those aged 20 to 65 and older 
but had an incidence rate of 0.26%, equivalent to 215,000 people, in 2010 for those 
under age 20. The estimated cost in 2012 of treating diagnosed cases of diabetes was 
$245 billion, with direct medical costs accounting for $176 billion. Further complications 
of the disease such as heart disease, kidney failure, stroke and amputations continue to 
exacerbate medial costs, accounting for approximately 10% of the costs associated with 
treating diabetes (1). 
Obesity is frequently associated with the disease and 85.2% patients diagnosed 
with type 2 diabetes mellitus (T2DM) are either overweight or obese. From 2009-2010, 
it was reported that 69.2% of the population was overweight or obese and a striking 
35.9% classified as obese (1). With over one third of the U.S. population suffering from 
obesity, it is paramount to address the economic, environmental and biological factors 
that contribute to T2DM. Although many risk factors have been attributed to T2DM 
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these vary widely among populations; with African Americans, Alaska Natives, American 
Indians, Hispanics/Latinos, Native Hawaiians, and Pacific Islander Americans being more 
susceptible than non-Hispanic whites (1). Despite evidence of some ethnic and genetic 
susceptibility, the evidence suggests physical inactivity and increased caloric intake are 
the greatest risk factors for developing T2DM (2). 
1.2. Obesity, Hyperinsulinemia and Insulin Resistance 
T2DM is the most prevalent form of diabetes, representing 90-95% of all adult 
cases of diabetes, and is a result of the body’s insensitivity to insulin concomitant with 
hyperinsulinemia, hyperglycemia, and dyslipidemia (3). T2DM is commonly preceded by 
prediabetes, which is characterized by elevated FBG levels ranging between 100-125 
mg/dL (5.6-6.9 mM). T2DM is characterized by fasting blood glucose levels above 126 
mg/dL (7 mM) and hemoglobin A1c levels above 6.5% on two separate tests (4).  
Insulin is produced by the pancreatic beta cells and is released in response to 
ingestion of a meal to facilitate the uptake of glucose into the peripheral tissues (5). In 
T2DM, there is a loss of insulin sensitivity in the peripheral tissues, despite 
hyperinsulinemia, resulting in sustained hyperglycemia (6). The insulin receptor and its 
signal transduction pathway have been extensively studied providing detailed insight 
into the intracellular mechanism of insulin signaling. Insulin binds to the insulin 
receptor, a tyrosine kinase receptor comprised of a dimer of αβ subunits. The alpha 
subunits reside on the outer leaflet of the lipid bilayer and contain the binding sites for 
insulin. The beta subunits are transmembrane helices with the carboxy termini residing 
in the cytosol (5). The alpha subunits inhibit the autophosphorylation of the beta 
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subunits in the absence of insulin. Upon binding of insulin, the inhibition is relieved and 
autophosphorylation activity of the beta subunits permits specific tyrosine residues to 
become phosphorylated. Insulin receptor substrate (IRS) proteins 1 and 2 have 20 
potential phosphorylation sites that can be regulated and serve to propagate the 
cascade of events induced by insulin and other growth factors. Insulin signaling appears 
to be primarily mediated through IRS, which generates the second messenger 
phosphatidylinositol (3,4,5)-triphosphate by activating phosphoinositide 3-kinase 
leading to phosphoinositide-dependent kinase-1 (PDK1) and phosphoinositide-
dependent kinase-2 /mammalian target of rapamycin complex 2 (mTORC2) activation. 
PDK1 and mTORC2 can phosphorylate Akt/protein kinase B (PKB) to promote cell 
growth and survival (7). Akt can also promote enhanced glucose uptake and storage and 
inhibit gluconeogenesis through suppression of forkhead transcription factor O1, or 
Foxo1. Alternatively, the activation of mammalian target of rapamycin complex 1 
mTORC1 via Akt is responsive to amino acids and promotes protein synthesis, 
lipogenesis and inhibition of autophagy. Defects in the insulin signaling pathway can 
result from mutations, loss of function or over/under phosphorylation giving rise to 
insulin resistance (7). 
As the body becomes less sensitive to insulin the pancreas continue to produce 
more insulin in an attempt to compensate for the reduction in glucose uptake. However, 
it has been shown that hyperinsulinemia can prevent glucose transporter type 4 (Glut4) 
trafficking to the membrane, further impairing glucose uptake (7). Additionally, the 
levels of IRS have been shown to be reduced, as activation of mTORC1 promotes their 
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ubiquitination and degradation. Activation of c-Jun N-Terminal kinase (JNK), a mitogen-
activated protein kinase (MAPK) primarily activated by cytokines, can lead to p-IRS1 
Ser307, impairing insulin sensitivity and this can be mediated by both tumor necrosis 
factor alpha (TNFα) and hyperlipidemia (7, 8, 9, 10). Therefore the combined effects of 
dysregulated glucose metabolism, dyslipidemia and inflammation, in addition to 
individual risk, are key factors in determining the progression of the disease (11).  
1.3. Symptoms and Treatment of Type 2 Diabetes Mellitus 
A newly diagnosed T2DM patient will have a range of symptoms including 
frequent urination, increased thirst and fatigue; which can be attributed to the elevated 
FBG from impaired tissue glucose uptake. In these individuals, the initial treatment 
consists of monitoring blood glucose levels in response to a pharmacological agent, 
coupled with diet and exercise. Metformin is the pharmacological agent of choice that 
primarily controls blood glucose levels through regulation of hepatic gluconeogenesis 
(12). Thiazolidinediones and sulfonylureas are additionally used when metformin alone 
does not have the efficacy to reduce blood glucose levels. Thiazolidinediones act as 
peroxisome proliferator-activated receptors (PPAR) agonists, altering the expression of 
genes involved in glucose and lipid metabolism (13) while sulfonylureas stimulate the 
pancreas to release insulin (14). Although these drugs can help reduce hyperglycemia 
there is currently no cure for T2DM. The patient’s quality of life with the disease 
depends on how well they manage their blood glucose levels, which can be enhanced 
through a healthy diet and regular physical activity. As the disease progresses 
complications in other organs such as the eyes, kidneys and nerves can arise (15). Many 
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of these tissues have non-insulin dependent glucose uptake and therefore their 
exposure to chronic hyperglycemia has been proposed to exacerbate cellular 
mitochondrial dysfunction. This results in increased superoxide production (oxidative 
stress) and intracellular damage in these tissues (16). 
1.4 Adipocyte Metabolism in Type 2 Diabetes Mellitus 
In healthy individuals the body responds to the ingestion of a meal by secreting 
insulin to facilitate glucose uptake into insulin sensitive tissues. In response to nutrient 
excess the adipose tissue can expand and store the surplus calories in the form of 
triglycerides (TGs). The storage capacity of the adipose tissue does not exceed its limit in 
healthy individuals and it contains a pool of preadipocytes that differentiate into 
adipocytes in response to nutrient excess. In the obese/diabetic individual, the 
hypertrophied adipocytes have lost their capacity to store excess fuel, resulting in the 
storage of fat in peripheral tissues such as liver and muscle (17).  
Adipose tissue is considered an endocrine organ as it secretes a range of 
hormones known as adipokines. Increased or decreased production of several of these 
hormones is correlated with obesity and/or T2DM. Leptin was one of the first 
adipokines shown to be involved in nutrient regulation, functioning to decrease food 
intake and increase energy expenditure via the central nervous system (CNS) (17). 
However, despite the hyperleptinemina in obese subjects, the hormonal response in the 
CNS is reduced due to leptin resistance (8). Adiponectin is also secreted from the 
adipocyte and is known to act in an insulin sensitizing manner, increasing fatty acid 
oxidation in the muscle and suppressing gluconeogenesis in the liver. Increased plasma 
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levels of adiponectin are associated with a decreased risk for T2DM, while decreased 
levels are observed in patients with T2DM (8). 
The energy stored in the form of adipocyte TGs are released as free fatty acids 
(FFAs) when required as fuel for peripheral tissues. Obesity occurs due to an imbalance 
in energy expenditure versus energy intake. In the obese state the white adipose tissue 
(WAT) takes on a markedly different phenotype. Adipose tissue is composed of a 
network of cells containing adipocytes and the stromal vascular fraction; comprised of 
macrophages, neutrophils, eosinophils, and endothelial cells (17). In the subcutaneous 
adipose tissue of humans with T2DM and the visceral adipose tissue of ob/ob and db/db 
mice, there is increased infiltration and proliferation of macrophages (18, 19). However, 
the immune response appears to be secondary to adipocyte dysfunction as 
hypertrophied adipocytes release more FFAs, which in turn leads to the recruitment of 
the immune cells (20).  Increased circulating FFAs can also lead to deposition of FFAs in 
other organs such as the liver resulting in non-alcoholic fatty liver disease (21). 
As the adipose tissue expands, angiogenesis does not keep pace with growth 
resulting in a hypoxic state that can lead to the induction of vascular endothelial growth 
factor (VEGF) and plasminogen activator inhibitor-1 (20). Both of these cytokines can 
modulate adiponectin gene expression, thereby compromising adiponectin mediated 
regulation of hepatic gluconeogenesis and fatty acid oxidation by the muscle (20). 
Further, in hypertrophied adipocytes, there is an increased secretion of the monocyte 
chemoattractant protein-1 (MCP- 1) that attracts immune cells and inflammatory 
cytokines, e.g. interleukin-6 (IL-6) and TNFα, which have been attributed to systemic 
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insulin resistance (8, 9, 20). Although adipose tissue is comprised of cell types including 
adipocytes and macrophages, recent evidence suggests that adipocyte dysfunction is an 
early player in the cascade of events that contributes to the development of T2DM (17). 
1.5 Adipocyte Stress 
Considering the burden of adipose tissue mass and the role of the adipocyte in 
energy metabolism, it is critical that we understand the mechanism of adipocyte 
dysfunction during the progression of diabetes. Increased metabolic flux in the 
adipocyte increases cellular oxygen consumption leading to increased production of 
reactive oxygen species (ROS) in T2DM (22). The production of ROS can lead to 
peroxidation of lipids forming the α,β-unsaturated aldehydes 4-hydroxy and 4-oxo 
trans-2,3 nonenal (23). These can react with cysteine, histidine and lysine residues to 
irreversibly modify proteins by carbonylation (23). In addition to mitochondrial derived 
oxidative stress, there is increased evidence of endoplasmic reticulum (ER) stress (ER 
stress) in the adipocyte in diabetes (24). 
It has previously been shown that the differentiation of 3T3-L1 fibroblasts (an 
established cell culture model for the study of adipogenesis) into 3T3-L1 adipocytes 
occurs through the induction of the unfolded protein response (UPR) and ER stress (25, 
26). During adipogenesis this response assists the differentiating endocrine cell through 
the up-regulation of chaperone proteins to help fold the newly synthesized proteins (25, 
26). The UPR is a normal homeostatic response to the accumulation of misfolded 
proteins in the ER. Upon induction of the UPR, glucose-regulated protein 
78/immunoglobulin-binding protein (Grp78/BiP) dissociates from the ER membrane to 
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help chaperone misfolded proteins. Oxidoreductase proteins such as protein disulfide 
isomerase (PDI) can then interact with the misfolded proteins in order to catalyze 
disulfide bond formation and correct folding, thereby relieving the pressure on the ER. 
When there is an accumulation of newly synthesized or misfolded proteins in the ER and 
chaperone mediated folding cannot keep pace and ER stress develops (25, 26). 
 There are three established pathways in the ER stress response (see Chapter 2, 
Introduction for more details). Briefly, in the absence of ER stress, Grp78/BiP is 
associated with 3 ER membrane spanning proteins: Inositol-requiring enzyme 1 (IRE1), 
which splices X-box binding protein 1 (XBP-1), activating transcription factor 6 (ATF6), 
and the RNA-dependent protein kinase-like ER kinase (PERK). However, during ER stress 
Grp78/BiP dissociates from these 3 membrane proteins and each of them initiates signal 
transduction pathways as part of the UPR. The net effect of this signaling is to cause up-
regulation of chaperone proteins and transient attenuation of protein translation 
(Figure 1.1) (26, 27, 28). 
1.6 Adipocyte Mitochondrial Stress 
In parallel with oxidative and ER stress, mitochondrial stress has been 
documented in adipocytes matured in high glucose and in the adipose tissue of diabetic 
mice (29, 30, 31, 32). The reaction of fumarate, a Krebs cycle metabolite, with the thiol 
group on protein cysteine residues forms the chemical modification S-(2-
succino)cysteine (2SC), also termed protein succination (Figure 1.2) (33). The levels of 
succinated proteins are increased in adipocytes matured in 30 mM glucose vs. 5 mM 
glucose and in the adipose tissue of diabetic mice (31, 32). Protein succination increases 
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due to mitochondrial stress in adipocytes matured in high glucose as a result of an 
increase in the ATP/ADP ratio. As a result of respiratory control, the electron transport 
chain is inhibited, which concomitantly increases the mitochondrial membrane potential 
(ΔΨm) and the NADH/NAD
+ ratio. Consequently the NAD+ dependent enzymes of the 
Krebs cycle are inhibited resulting in increased fumarate and protein succination (30). 
The identity of ~40 succinated proteins in adipocytes has been confirmed (34) and 
further analysis of several of these has demonstrated that succination is associated with 
impaired structure or function (29, 35). For example, succination of adiponectin on 
cysteine 39 inhibits its polymerization into the biologically active high molecular weight 
form and thus it is not secreted but retained in the adipocyte. This provides a unique 
explanation for the impaired secretion and reduced circulating levels of this hormone in 
diabetes (29). Additionally we have shown that PDI, an ER chaperone protein, is 
succinated on an active site cysteine, thereby reducing its activity and potentially 
exacerbating ER stress in diabetes (unpublished results).  
In this thesis I propose that protein succination, as a direct result of 
mitochondrial stress, is a unique contributor to ER stress by causing misfolded proteins 
to accumulate in the ER.  I expect to observe increased ER stress in adipocytes matured 
in 30 mM glucose (high) vs. 5 mM (normal) glucose and I propose that chemical agents 
that reduce protein succination will lead to a decrease in ER stress. By demonstrating 
that reducing protein succination relieves ER stress, I hope to identify a new mechanism 
by which glucotoxicity contributes to adipocyte dysfunction. 
10 
 
 
 
Figure 1.1: ER stress pathway. Protein misfolding in the ER induces the UPR. There are 3 
signaling arms of the UPR that are activated upon increased protein misfolding: 
activation of (1) IRE1 leads to spliced (s) (XBP-1) and (2) ATF6 which leads to 
transcriptional up-regulation of chaperone proteins. The third arm involves PERK, which 
oversees the attenuation of nascent protein translation via phosphorylation of 
eukaryotic initiation factor 2 alpha (eIF2α). Further, activation of ATF4 leads to 
transcriptional up-regulation of CCAAT/enhancer binding protein (C/EBP) homologous 
protein (CHOP) (27), a terminal response to ER stress (28). 
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Figure 1.2: Formation of 2-(S-succino)cysteine (2SC). The reaction of fumarate with 
cysteine residues on proteins to form 2SC (33). 
12 
 
 
 
Figure 1.3: Glucotoxicity Driven Mitochondrial Stress increases Protein Succination.  
Increased extracellular glucose concentrations contribute to mitochondrial stress as 
increased metabolism increases the ATP/ADP ratio. Accumulation of ATP inhibits the 
electron transport chain, increasing the mitochondrial membrane potential (ΔΨm) and 
the NADH/NAD+ ratio, consequently inhibiting the NAD+-dependent enzymes of the 
Krebs cycle. Inhibition of the Krebs cycle enzymes increases fumarate concentrations, 
allowing free protein thiol groups on cysteine residues (PrSH) to react with fumarate 
forming succinated proteins (Pr-2SC) (34). 
13 
 
Chapter II 
Adipocyte Mitochondrial Metabolism and ER Stress 
2.1. Introduction 
The 3T3-L1 adipocyte model is a widely accepted model for the study of 
adipocyte function in obesity and diabetes (36). These studies are frequently conducted 
in the presence of high glucose concentrations (25-30 mM), as many cell lines are 
commonly maintained under these conditions. However, recent reports have 
documented that extracellular glucose concentrations have a significant impact on the 
measurement of mitochondrial bioenergetics (37), which is of importance for 
experimental conditions examining mitochondrial function in diabetes. While several 
studies have examined adipocytes cultured in both 5 mM (normal) and 25-30 mM (high) 
glucose (38, 39, 40) the majority of published studies appear to be conducted in high 
glucose medium. The Seahorse Extracellular Flux Analyzer (XF) 24 allows for the 
measurement of the oxygen consumption rate (OCR) in a respiring cell. In addition, the 
use of several chemical compounds that interfere with respiratory chain components 
allows assessment of several parameters of mitochondrial function. These include basal 
respiration, ATP synthesis coupled to oxygen consumption, proton leak (using 
oligomycin), spare respiratory capacity (SRC) (using an uncoupler e.g. carbonyl cyanide 
4-(trifluoromethoxy) phenylhydrazone (FCCP)) and non-mitochondrial respiration (NMR) 
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(using rotenone/antimycin A) (Figure 2.1) (41). We hypothesized that adipocytes 
matured in 30 mM glucose versus 5 mM glucose would have an increased OCR and 
produce more ATP coupled to oxygen consumption. In addition, a recent report by Han 
et al. suggested that the majority of oxygen consumption in the cell was attributable to 
NMR (22). We wanted to investigate these claims as we have observed increased 
mitochondrial stress in the 3T3-L1 adipocyte (30, 31). Our overall aim was to compare 
the mitochondrial bioenergetic profile of adipocytes matured in 5 mM glucose (normal 
glucose) versus 30 mM glucose (high glucose). 
The process of adipogenesis involves a change in phenotype from either a 
fibroblast (in vitro) or a preadipocyte (in vivo) into an adipocyte (17). When adipocytes 
are matured in high glucose, adipogenesis is accompanied by activation of the UPR as 
these cells change phenotype (25, 26). UPR driven increases in chaperone proteins can 
assist in the folding of newly synthesized proteins destined for secretion from the 
adipocyte. When the UPR is initiated, Grp78 dissociates from monomeric protein kinase 
RNA-like endoplasmic reticulum kinase (PERK), which is embedded in the ER membrane. 
This particular arm of the UPR has recently been confirmed as the most important 
signaling arm in adipocytes undergoing adipogenesis (25, 26). PERK then homodimerizes 
and is activated by autophosphorylation. Eukaryotic initiation factor α (eIF2α) is then 
phosphorylated by PERK at Ser-51 leading to an attenuation of protein translation. This 
response transiently relieves the cell from the burden of accumulating proteins (26). 
Downstream of p-eIF2α the activating transcription factor 4 (ATF4) translocates to the 
nucleus and up-regulates CCAAT/enhancer binding protein (C/EBP) homologous protein 
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(CHOP). The up-regulation of CHOP leads to the induction of growth arrest and DNA 
damage-inducible protein (GADD34), causing dephosphorylation eIF2α and restoration 
of cellular protein synthesis (Figure 1.1) (42). However, prolonged induction of CHOP is 
also associated with terminal ER stress and the induction of cellular apoptosis Figure 
2.2) (27, 42-46). 
 Several studies have shown that the UPR and ER stress occur during 
adipogenesis in both high glucose (25 mM or 30 mM) and high insulin (25, 26). However, 
these conditions are not ‘normal’ and are instead comparable to diabetic conditions. 
Therefore, we hypothesized that activation of the UPR was only occurring as a result of 
the diabetic culture conditions and we predicted that cells matured in 5 mM (normal 
glucose) would not have an up-regulated UPR or ER stress response. To test the 
relationship between high glucose/insulin and UPR activation we compared adipocytes 
matured in 5 mM glucose/0.3 nM insulin (normal conditions) versus 30 mM glucose /3 
nM insulin (diabetic conditions). We examined markers of adipocyte differentiation to 
ensure that the 3T3-L1 fibroblasts had undergone a phenotypic change into an 
adipocyte. We also assessed UPR/ER stress markers throughout the course of adipocyte 
maturation to compare the effects of the different glucose/insulin conditions.  
2.2. Results 
The respiratory profile of 3T3-L1 adipocytes matured in high glucose (30 mM) 
conditions has been described previously (23), however these conditions correspond to 
what could be considered a hyperglycemic, hyperinsulinemic environment and are not 
appropriate ‘control’ conditions for the study of normal adipocyte respiration. The 
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Seahorse XF24 was used to contrast the OCR of adipocytes after 2 days maturation (M2) 
in either 5 mM or 30 mM glucose. The glucose/insulin concentrations used were 5 
mM/0.3 nM and 30 mM/3 nM to reflect concentrations similar to normal post-prandial 
conditions and a hyperglycemic/hyperinsulinemic state, respectively. A representative 
trace is shown in Figure 2.3A, illustrating the basal bioenergetic profile of adipocytes 
followed by ATP synthase inhibition (oligomycin), membrane depolarization with FCCP 
and complex I/complex II inhibition (rotenone/antimycin A), as denoted by the arrows. 
There was ~1.7-fold increase in the basal respiration and ~1.8-fold increase in ATP 
synthesis coupled to oxygen consumption in adipocytes grown in high glucose (gray 
bars) vs. normal glucose (black bars) (***p<0.001, Figure 2.3B). Proton leak and NMR 
were also significantly increased in high glucose (**p<0.01, Figure 2.3B). However, the 
SRC, a measure of the cellular capacity to increase mitochondrial respiration under 
stress, was ~2.4-fold lower in high glucose vs. normal glucose (***p<0.001, Figure 2.3B). 
Several studies have described ER stress as a requirement for 3T3-L1 fibroblasts to 
undergo differentiation into 3T3-L1 adipocytes using high glucose and high insulin 
conditions (25, 26). To determine if only high glucose could induce ER stress we 
conducted adipocyte maturation in normal or high glucose/insulin and assessed several 
markers of both adipogenic differentiation and the UPR/ER stress. The production of 
adiponectin and PPARγ confirmed that the 3T3-L1 fibroblasts (F) had differentiated and 
matured into adipocytes in both 5 mM and 30 mM glucose during the 11 day time 
course (3 days differentiation (D) in 30 mM glucose followed by 8 days in 5 mM/0.3 nM 
or 30 mM/3 nM glucose/insulin maturation medium (M1-M8), Figure 2.4A). Notably, 
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adipocytes matured in 30 mM glucose had decreased total adiponectin levels vs. those 
cultured in 5 mM glucose towards the end of maturation (M7 and M8) (Figure 2.4A&B, 
lanes 16-23). Markers of the UPR and ER stress were upregulated in adipocytes as they 
begin maturation in either normal or high glucose. Grp78 increased throughout 
maturation in normal and high glucose, with a peak level occurring in 5 mM glucose at 
M5 (Figure 2.3C). PDI, endoplasmic reticulum oxidoreductin-1-like protein (Ero1-Lα) and 
p-eIF2α were most pronounced during days M1-5 of maturation in both normal and 
high glucose and declined thereafter until day M8 (M1-M8, Figure 2.4A, Lanes 4-23). 
Concomitant with a decrease in p-eIF2α levels there was a pronounced increase in CHOP 
levels in adipocytes, but notably this was only in the cells matured in 30 mM glucose 
(Figure 2.4A&E). Consistent with previous results (29, 31), the post-translational 
modification 2SC increased in adipocytes matured in 30 mM glucose for up to 8 days 
(M2-M8, lanes 8-23), and interestingly appeared to increase in parallel with CHOP levels 
(Figure 2.4A). In addition to the observed decrease in adiponectin detected in Figure 2.4, 
the adipocytes matured in 30 mM glucose secreted increased levels of pro-
inflammatory cytokines, including TNFα, VEGF and MCP-1 (Figure 2.5A-C) versus those 
matured in 5 mM glucose. Taken together, these results confirm that increased protein 
succination occurs in parallel with increased ER stress (CHOP), decreased adiponectin 
production and elevated pro-inflammatory cytokine production when adipocytes are 
matured in high glucose conditions. 
 Recent work has suggested that insulin alone is sufficient to increase ER stress in 
adipocytes and adipose tissue (47, 48). Considering that our 5 mM glucose adipocytes 
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are cultured in 0.3 nM insulin and our 30 mM glucose adipocytes are cultured in 3 nM 
insulin, we investigated if the combined increases in 2SC and CHOP that we observed 
were due to either the glucotoxicity or the high insulin concentration. To do this we 
examined ER stress and protein succination in the absence/presence of 10 nM insulin 
with both 5 mM and 30 mM glucose. As observed in Figure 2.6, the addition of insulin 
leads to increased protein succination in adipocytes matured in 30 mM glucose (lanes 7-
12) and has no effect on the levels of protein succination in adipocytes matured in 5 mM 
glucose (lanes 1-6), therefore it appears that combined glucotoxicity and elevated 
insulin are required to observe this biomarker of mitochondrial stress. Grp78 levels 
were measured to assess UPR activation and suggested that insulin leads to the 
induction of the UPR (lanes 1-3 vs. 4-6 or lanes 7-9 vs. 10-12), independent of glucose 
concentration. We then measured CHOP levels, and observed a pronounced increase in 
CHOP in 30 mM glucose with an added response in the presence of insulin. However, 
CHOP was unchanged in 5 mM glucose with or without insulin (Figure 2.6), indicating 
that both high insulin and glucotoxicity are necessary for the maximal induction of 
CHOP. 
 
2.3. Discussion 
The differentiation of 3T3-L1 fibroblasts into adipocytes has been extensively 
studied (36), with adipocyte maturation commonly occurring in 25 mM (~450 mg/dL) 
glucose and insulin concentrations ranging from 10-1700 nM (23, 48), well beyond the 
physiological range. In this study, we compared adipocytes matured in 5 mM 
glucose/0.3 nM insulin or 30 mM glucose/3 nM insulin to better reflect normal and 
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diabetic conditions, respectively. We examined the respiratory profile of adipocytes that 
had matured in 5 mM or 30 mM glucose for 2 days and observed that the adipocytes 
matured in 30 mM glucose had a ~1.7-fold increase in the basal respiration rate (Figure 
2.3A&B). In contrast, the spare respiratory capacity, a measure of mitochondrial 
capacity to increase the rate of oxygen consumption, was ~2.4-fold lower in high 
glucose versus normal glucose. This data indicates that adipocytes matured in high 
glucose conditions are already respiring close to their maximal capacity and are not 
optimal for use as ‘healthy’ controls for normal adipocyte function. Recent reports have 
suggested that 3T3-L1 adipocytes predominantly consume oxygen in non-mitochondrial 
pathways (22). However, our OCR measurements allowed us to assess both 
mitochondrial and non-mitochondrial oxygen consumption as they included a final 
rotenone/antimycin A inhibition of Complex I/III, effectively inhibiting mitochondrial 
respiration. Our data demonstrate that non-mitochondrial respiration accounts for 
~22% of the OCR (Figure 2.3B, NMR). This indicates that while non-mitochondrial 
respiration is significant, it is not the major source of oxygen consumption in the 3T3-L1 
adipocyte model.  ATP production coupled to oxygen consumption was increased in high 
glucose (Figure 2.3B, ATP) confirming our previous observations of an increased 
ATP/ADP ratio in adipocytes cultured in 30 mM glucose (30).  
 Recently, Valsecchi et al. highlighted the importance of glucose concentration for 
the study of mitochondrial (dys)function. They noted that primary cultures in the 
presence of high glucose do not show differences in ROS measurements that are 
observed when the same cells are cultured in normal glucose. Moreover, immortalized 
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cell lines that are frequently used to study mitochondrial function in high glucose have 
high glycolytic activity, rather than a dependence on mitochondrial metabolism (37). 
Additionally, increased proton leak in adipocytes matured in 30 mM glucose suggests 
there may be inner mitochondrial membrane damage or electron slippage (49). We 
have demonstrated that there are significant differences in the mitochondrial 
respiratory profile of adipocytes matured in 5 mM and 30 mM glucose. Adipocytes 
matured in high glucose are consuming more oxygen and therefore produce more ATP 
and have increased NMR and proton leak. This suggests that adipocytes matured in 30 
mM glucose are not healthy controls as it appears their mitochondria are working closer 
to their maximal capacity and may have impaired electron transport chain complexes or 
integrity (49). 
We investigated if UPR/ER stress during adipogenesis (25, 26) was unique to cells 
cultured in high glucose or if the UPR and ER stress were still increased when cells were 
cultured in 5 mM (normal) glucose. As shown in Figure 2.4A, both adipocytes cultured in 
normal or high glucose proceed through differentiation (D) and maturation (M) normally 
as indicated by the significant increase in PPARγ and adiponectin.  Several markers of 
the UPR including Grp78, PDI and p-eIF2α were increased, confirming that UPR 
activation is actually a normal component of 3T3-L1 adipogenesis (25, 26), not only in 30 
mM glucose but also in 5 mM glucose. Although there were subtle changes in UPR 
markers between 5 mM and 30 mM glucose at various time points, these changes were 
not significant (Figure 2.4A-D), but CHOP, a downstream marker of ER stress, was 
significantly increased as maturation progressed, most notably in 30 mM glucose (Figure 
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2.4A&E, M2-M8). Interestingly, as CHOP levels increased in 30 mM glucose this was 
associated with an increase in protein succination, a biomarker of mitochondrial stress 
(Figure 2.4A, anti-2SC). The increase in CHOP and succinated proteins corresponded to a 
decrease in total adiponectin levels at days M7 – M8 in 30 mM vs. 5 mM glucose (Figure 
2.4A) and was also associated with an increase in the release of the pro-inflammatory 
markers TNF-α, MCP-1 and VEGF into the medium (Figure 2.5A-C). Han et al. have also 
demonstrated that adipocytes matured in 25 mM glucose have increased adipocyte-
derived factors such as serum amyloid A and hyaluronan that facilitate monocyte 
recruitment and adhesion (40). This evidence suggests that glucose has intrinsic effects 
on the adipocyte that lead to metabolic stress and cellular dysfunction. Taken together, 
this data confirms that UPR activation is a normal aspect of 3T3-L1 adipogenesis and 
activation; however the sustained increase in CHOP is associated with mitochondrial 
stress, protein succination, and adipocyte inflammation and is unique to high glucose 
culture conditions (glucotoxicity). 
Increased CHOP levels have classically been associated with the induction of 
apoptosis during ER stress (42, 43, 44, 45), however, our data suggests that CHOP may 
be increased independent of an apoptotic response, as there was no increase in cleaved 
caspase-3 at this stage of maturation (data not shown). Many recent reports have 
described alternative functions of CHOP unrelated to apoptosis, e.g. Han et al. have 
demonstrated that CHOP induction can inhibit adipogenesis in 3T3-L1 fibroblasts and 
mouse embryonic fibroblasts (MEFs) (26). Han et al. have also identified CHOP 
transcription binding sites in genes involved in protein synthesis such as tRNAs and 
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initiation factors. Interestingly, no apoptotic genes were found to be directly associated 
with transcriptional activation by CHOP (27). In C57BL/6J mice, CHOP was shown to 
suppress transcription of metabolic genes in the liver during ER stress (50), providing 
further evidence that CHOP is more promiscuous than once thought and its role is not 
limited to apoptotic events. This suggests that CHOP signaling is dependent on the 
nature of the stress signal and that the presence of CHOP in the cell is not necessarily 
indicative of an apoptotic response. 
To determine whether the glucose or the insulin was the inducer of ER stress, we 
matured adipocytes in 5 mM or 30 mM with and without 10 nM insulin. We observed 
that insulin induced the UPR in both 5 mM and 30 mM glucose by upregulating Grp78 
protein levels, but only high glucose and high insulin combined led to ER stress and 
mitochondrial stress as observed by CHOP and succinated protein levels, respectively 
(Figure 2.6). This confirms our earlier result indicating that adipocytes matured in high 
glucose are not healthy controls and are already under a state of stress, highlighting the 
importance of both glucose and insulin conditions for the study of mitochondrial 
bioenergetics and ER stress in the context of diabetes research.  
Overall, the direct correlation between succination and CHOP levels raises the 
interesting possibility that mitochondrial stress and 2SC may have a role in sustained 
CHOP signaling. Kelch-like ECH-associated protein 1 (Keap1) has recently been described 
as a negative regulator of CHOP in adipocytes (51) and we have shown that Keap1 
cysteines are succinated in fumarate hydratase deficient fibroblasts (52). We 
hypothesize that increased succination of Keap1 may promote CHOP stability to allow 
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sustained CHOP signaling, independent of ER stress, and this is the subject of ongoing 
investigations in our laboratory. 
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Figure 2.1. Schematic of bioenergetic profile generated from the Seahorse XF24. The 
bioenergetic profile of a respiring cell can be generated using the Seahrose XF24. The 
oxygen consumption rate (OCR) allows for the measurement of basal respiration, ATP 
production coupled to oxygen consumption, spare respiratory capacity (SRC), proton 
leak, and non-mitochondrial respiration (NMR) can be measured following the addition 
of specific chemical inhibitors as denoted by the arrows (41). 
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Figure 2.2 ER stress leads to apoptosis via upregulation of CHOP. ER stress leads to the 
induction of CHOP (See Figure 1.1 for more details) and cellular caspases ultimately 
leading to apoptosis (46). 
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Figure 2.3 A & B: Bioenergetic profile of 3T3-L1 adipocytes in 5 mM and 30 mM 
glucose. (A) The respiratory profile of adipocytes cultured in 5 mM (black squares/black 
bars) or 30 mM glucose (gray squares/gray bars) was measured after 2 days maturation 
using the Seahorse XF24 Analyzer as described in the Materials and Methods. Drugs 
were added at the indicated arrows to assess mitochondrial function. (B) Basal, ATP 
production (ATP), spare respiratory capacity (SRC), proton leak (H+ leak), and non-
mitochondrial respiration (NMR) were measured following the addition of oligomycin 
(O), FCCP (F), and rotenone/antimycin A (R/A) respectively. Data are representative of 
n=4 measurements expressed as means ± S.D. Asterisks indicate statistical significance 
determined by an unpaired Student t test (**P<0.01 and ***P<0.001 for 30 mM glucose 
(gray bars) vs. 5 mM glucose (black bars). A Mann-Whitney Rank Sum Test was 
performed on data not normally distributed. 
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Figure 2.4 A: Adipogenesis proceeds via ER stress in normal or high glucose. (A) Time 
course detailing markers of adipogenic differentiation and UPR/ER stress in adipocytes 
cultured 5 mM (normal) or 30 mM (high) glucose. Total cell lysates (20 μg protein) from 
adipocytes harvested at the indicated time points were separated by 1-D PAGE. 
Adipogenic proteins and UPR/ER stress markers were detected as described in the 
Materials and Methods. F represents fibroblasts, D represent cells undergoing 
differentiation and M represents the maturation period in days in either 5 mM or 30 
mM glucose. A representative Coomassie is shown as a loading control.  
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Figure 2.4 B-C: Adipogenesis proceeds via ER stress in normal or high glucose. 
Quantification of band densitometry in Figure 2.3A for adipocytes matured in 5 mM 
(black circles) or 30 mM (gray circles) glucose. (B) Adiponectin. (C) p-eIF2α. (D) Grp78. 
(E) CHOP. 
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Figure 2.5: Increased secretion of inflammatory markers in high glucose. Secreted 
levels of pro-inflammatory cytokines as measure by mouse obesity ELISA as described in 
the Materials and Methods. (A) TNFα. (B) VEGF. (C) MCP-1. Data are representative of 
n=4 measurements expressed as means ± S.D. Asterisks indicate statistical significance 
determined by an unpaired Student t test (**P<0.01 and ***P<0.001 for 30 mM glucose 
(gray bars) vs. 5 mM glucose (black bars)). 
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Figure 2.6: Insulin induces the UPR while added glucotoxicity activates the ER stress 
response. 3T3-L1 adipocytes were matured in either 5 mM or 30 mM glucose for 8 days 
in the absence/presence of 10 nM insulin. Protein, 20 μg, was separated by 1-D PAGE 
and 2SC, Grp78 (UPR) and CHOP (ER stress) were detected as described in Materials and 
Methods.
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Chapter III 
Is sodium phenylbutyrate a mitochondrial uncoupler? 
3.1. Introduction 
 There are two types of adipose tissue found in mammals, white adipose tissue 
(WAT) and brown adipose tissue (BAT), both of which are responsive to insulin and can 
store TGs (53). WAT is the predominant form of AT in humans making up the bulk of fat, 
while BAT is a specialized tissue that plays a more prominent role in thermogenesis. BAT 
expresses uncoupling protein-1 (UCP-1) which is located in the mitochondria and can 
uncouple oxygen consumption from ATP synthesis, thereby dissipating the 
mitochondrial membrane potential and releasing energy in the form of heat (17). This 
effect of uncoupling AT has received attention as a possible therapeutic mechanism for 
weight loss, as it was first documented in the early 1900’s that consumption of 2,4-
dinitrophenol (DNP) led to weight loss. However, DNP is also known to be carcinogenic 
and is no longer clinically recommended for weight loss (54). 
 Using an in vitro model there are several chemicals that can be used as 
depolarization agents to study the effects of dissipating the ΔΨm. These include FCCP, 
carbonyl cyanide 3-chlorophenylhydrazone (CCCP) and DNP. These chemicals act as 
uncouplers by carrying a proton from the mitochondrial matrix across the inner 
membrane and consuming oxygen without producing ATP. Addition of an uncoupler to a 
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respiring cell will depolarize the ΔΨm, leading to an increase in the OCR as the protons 
are carried across the inner membrane without simultaneous production of ATP. We 
have previously shown that treatment of 3T3-L1 adipocytes with CCCP or salicylic acid 
(SA) (acting as a mild uncoupler) decreases the ΔΨm (30). Therefore, we were interested 
in examining other agents that may also be acting as chemical uncouplers as we 
predicted that they would lead to a decrease in mitochondrial stress and consequently 
protein succination. We had observed that 3T3-L1 adipocytes treated with 1 mM 
sodium phenylbutyrate (PBA) for 8 days during maturation had reduced protein 
succination and a reduced ΔΨm. In other studies, PBA is currently being explored as a 
possible therapeutic agent for the treatment of ER stress in adipose tissue (55). 
However, considering that PBA and SA are similar in structure (Figure 3.1) and that SA 
has been shown to act as a mitochondrial uncoupler (56), we hypothesized that PBA 
may also be acting as a mitochondrial depolarization agent. 
3.2. Results 
PBA has been shown to lower ER stress in 3T3-L1 adipocytes matured in high 
glucose (25); therefore we examined the effect of PBA on mitochondrial stress and 
protein succination. As demonstrated in Figure 3.2A, adipocytes matured in high glucose 
have increased levels of 2SC compared to adipocytes matured in normal glucose for 8 
days. When treated with 1 mM PBA for 8 days, the levels of 2SC in adipocytes matured 
in high glucose are significantly reduced and remain unchanged in normal glucose 
(Figure 3.2A). Next, we measured the ΔΨm using a mitochondrial membrane permeable 
dye. CCCP was used as a positive control as this uncoupler has been shown to reduce 
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the levels of protein succination (30). In Figure 3.2B, CCCP reduced the ΔΨm (
***P<0.001) 
as expected, however, PBA treatment also reduced ΔΨm ~60% (
***P<0.001) compared to 
untreated 30 mM glucose adipocytes. 
PBA has also been documented to inhibit adipogenesis in vitro (25). We also 
observed a significant reduction in PPARγ, the master regulator of adipogenesis, after 
treatment with 1 mM PBA (Figure 3.3A). Adipocyte triglyceride content was decreased 
in a dose dependent manner after 2 and 8 days of PBA treatment versus 30 mM glucose 
alone (*P<0.05, Figure 3.3B&C). We next quantified the extracellular glucose 
concentrations in order to determine if PBA altered glucose uptake into the adipocyte. 
There was a significant amount of glucose remaining in the medium after 2 days of 
treatment with 1 mM PBA (***P<0.001, Figure 3.3D) versus untreated cells. 
Considering the reduction in ΔΨm observed after PBA treatment (Figure 3.2A), 
we hypothesized that PBA may be acting as a mitochondrial depolarization agent. Using 
the Seahorse XF24, we compared the ability of PBA to decrease the ΔΨm and 
subsequently increase the OCR versus FCCP or SA. FCCP uncoupled oxidative 
phosphorylation at previously titered micromolar concentrations, as demonstrated by 
the rapid increase in the OCR (Figure 3.4A, black/solid triangles, first arrow denotes 
addition of FCCP). We have previously shown that SA reduces both the ΔΨm and the 
levels of 2SC-modified proteins in adipocytes matured in high glucose (30). Here, we 
confirmed that SA is acting as a mild uncoupler as increasing concentrations of SA 
depolarized the inner mitochondrial membrane leading to successive increases in the 
OCR (gray circles, Figure 3.4A, arrows denote addition of SA). In contrast, increasing 
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concentrations of 1 mM, 5 mM and 10 mM PBA (Figure 3.4A, black circles, arrows 
denote addition of PBA) did not appear to increase the OCR above the basal rate (Figure 
3.4A), although the marginal increase was statistically significant with 10 mM PBA 
(***P<0.001, Figure 3.4B). As the affects after acute PBA treatment were minimal, we 
next examined the OCR after treatment with 1 mM or 5 mM PBA for 2 days. 
Interestingly, the basal OCR was significantly reduced in adipocytes matured in 30 mM 
glucose treated with 1 mM and 5 mM PBA (red circles vs. black triangles, red circles vs. 
green triangles Figure 3.4C, striped and checked bars vs. gray bars, basal respiration, 
***P<0.001, Figure 3.4D). Other bioenergetic parameters such as oxygen-coupled ATP 
synthesis and NMR were significantly reduced with 5 mM PBA treatment compared to 
adipocytes matured in 30 mM glucose (*P<0.05, Figure 3.4D). Proton leak was 
significantly reduced with 1 mM and 5 mM PBA treatment compared to adipocytes 
matured in 30 mM glucose alone (***P<0.001, Figure 3.4D). Notably, 1 mM PBA 
preserved the ability of the adipocytes to respond to FCCP uncoupled respiration, 
whereas 5 mM PBA reduced the SRC (***P<0.001, Figure 3.4D). PBA treatment reduced 
both the adiponectin and the PPARγ content in the adipocytes, highlighting that PBA 
reduces markers of adipogenesis as early as 2 days (Figure 3.5A). As expected PBA 
treatment lowered the UPR as noted by reductions in calreticulin, PDI and p-eIF2α 
levels, particularly with 5 mM PBA. However, we observed that both CHOP cleaved 
caspase-3 levels were significantly increased in the presence of 5 mM PBA (Figure 3.5A), 
indicating that elevated PBA concentrations actually induce ER stress and lead to 
apoptosis. This was consistent with our observation that 5 mM PBA mildly reduced cell 
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viability (data not shown). Although PBA treatment did not reduce the mitochondrial 
DNA copy number (Figure 3.5B), there was a reduction in the protein levels of several 
mitochondrial proteins including succinate dehydrogenase (SDHA) and NADH 
dehydrogenase [ubiquinone] iron-sulfur protein 4 (NDUFS4, a component of 
mitochondrial complex I), versus the 30 mM glucose controls (Figure 3.5A), suggesting 
that PBA may selectively lower the levels of some mitochondrial proteins. 
3.3. Discussion  
Protein succination appears to be a biomarker of adipocyte dysfunction and 
increases as a consequence of mitochondrial stress. The increase in fumarate is 
associated with an increased ATP/ADP ratio, elevated ΔΨm and increased NADH/NAD
+ 
(Figure 1.3) and this can be reduced after treatment with CCCP, a mitochondrial 
depolarization agent (30). To determine if mitochondrial stress and ER stress were 
linked, we treated adipocytes with 1 mM PBA and observed a significant reduction in 
succination and also the ΔΨm (Figure 3.2A&B). We hypothesized that PBA may be acting 
as a depolarization agent, given that there was a reduction in the ΔΨm upon treatment 
of adipocytes in 30 mM glucose with PBA (Figure 3.2B). Using the Seahorse XF 24 we 
added PBA to respiring adipocytes to determine if it had an acute effect on increasing 
the OCR. In contrast to known uncouplers such as FCCP and SA, we did not observe an 
appreciable increase in the OCR with 1 mM or 5 mM PBA (Figure 3.4A), confirming that 
PBA was not acting as an uncoupler at low doses. Although 10 mM PBA increased the 
basal OCR, it is not a tolerable dose as 5 mM PBA increased the levels of caspase-3 in 
adipocytes after 2 days treatment. Rather, when the adipocytes were treated with PBA 
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for 2 days we noted a decrease in the basal OCR and ATP production coupled to oxygen 
consumption (Figure 3.4C&D), which is consistent with the decrease in the ΔΨm. After 
further investigation we observed a reduction in the mitochondrial protein content, as 
noted by a decrease in SDHA and NDUFS4, but there was no change in the 
mitochondrial copy number (Figure 3.5A&B). Despite the reduction in the mitochondrial 
protein content with 1 mM PBA, the mitochondria still had the ability to increase the 
SRC when challenged with an uncoupler (Figure 3.4D, SRC). Additionally, basal 
respiration was decreased with 1 mM PBA treatment but ATP synthesis coupled to 
oxygen consumption remained unchanged, which may be attributed to decreased 
proton leak and enhanced membrane integrity (49). We also observed that PBA reduced 
glucose uptake by the adipocyte (Figure 3.3D), suggesting that the OCR may be reduced 
in part due to reduced metabolic flux (Figure 3.4D), providing further explanation for the 
decrease in mitochondrial protein content without a decrease in the SRC when 30 mM 
glucose is present. This is in contrast to in vivo studies using ob/ob mice where PBA was 
shown to reduce blood glucose levels after just 4 days of treatment, suggesting that it 
facilitates glucose uptake in an animal model of obesity (57). However, another report 
indicated that PBA had no effect on blood glucose in other models of diabetes such as 
the alloxan-induced diabetic mice or the Goto-Kakizaki rat (58). Therefore, it will be 
necessary to determine if PBA alters hyperglycemia in diabetic humans as cellular and 
animal models do not appear to show consistent effects. 
PBA has been described as a chemical chaperone that can alleviate ER stress in 
the liver of ob/ob mice and the adipose tissue of ob/ob and high fat diet fed mice (25, 
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57). Basseri et al. further characterized PBA as an agent that can inhibit adipogenesis in 
vitro (25). In keeping with these results, we observed a decrease in PPARγ and 
adiponectin when adipocytes were treated with PBA (Figure 3.3A and 3.5A). Consistent 
with inhibition of adipogenesis, there is a dose dependent reduction in TG levels when 
adipocytes are treated with PBA during days 0-2 of maturation (Figure 3.3B&C). The UPR 
was also reduced by PBA as noted by the decrease in calreticulin and p-eIF2α (Figure 
3.5A) but interestingly CHOP levels increased with PBA treatment.  
ER stress induced production of CHOP has previously been linked with the 
induction of apoptosis (42-45) but recent reports have demonstrated CHOP also 
regulates adipogenesis (25) and it up-regulates genes involved in the UPR (27). More 
importantly, this study demonstrated that CHOP does not bind to promoter regions of 
genes involved in apoptosis, but instead found that CHOP bound to promoter regions of 
genes involved in protein synthesis, such as tRNAs and initiation factors. However, 
through forced production of CHOP, they demonstrated that premature restoration of 
protein synthesis could lead to cell death through the production of ROS and ATP 
depletion, suggesting that there is a delicate balance between the pro and anti-
apoptotic CHOP actions within the cell (27). This is also supported by the increased 
levels of CHOP and cleaved caspase-3, a marker of cellular apoptosis, that we observed 
with 5 mM but not 1 mM PBA (Figure 3.5A). Taken together, our data indicate that PBA 
may inhibit adipogenesis in vitro through the forced production of CHOP, but that higher 
concentrations of PBA (>1 mM) further increase CHOP levels and may lead to cell death 
if ER stress is relieved before cellular homeostasis is restored.  
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Overall, while in vitro data suggest that there may be a therapeutic window for 
PBA, careful consideration must be taken when treating cells with PBA as ER stress is 
ultimately a protective response and premature relief from ER stress can initiate 
apoptotic events. In addition, enabling adipose expansion and the recruitment 
preadipocytes is a plausible therapeutic strategy for T2DM. However, our in vitro data 
suggest PBA might not be beneficial as it reduced the protein levels of PPARα and 
adiponectin leading to impaired adipogenesis.  
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Figure 3.1 Chemical structure of sodium salicylate (SA) and sodium phenylbutyrate 
(PBA). 
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Figure 3.2: PBA reduces mitochondrial stress and 2SC levels. (A). Adipocytes were 
matured in 5 mM or 30 mM glucose with or without 1 mM PBA for 8 days. Total protein 
was harvested and 30 μg of protein was separated by 1-D PAGE and probed with anti-
2SC polyclonal antibody to detect protein succination. (B) Adipocytes cultured in 5 mM 
glucose, 30 mM glucose or 30 mM glucose + 10 µM CCCP or 1 mM PBA for 2 days were 
loaded with the dye JC-1 to measure the ΔΨm. After 20 min the cells were washed and 
fluorescence was measured at Ex/Em 550/600 nm and Ex/Em 485/535 nm, as described 
in Materials and Methods. The ΔΨm is expressed as a ratio of fluorescence at 600/535 
nm. Data are representative of n=4 measurements expressed as means ± S.D. Asterisks 
indicate statistical significance determined by a one way ANOVA using Tukey’s post hoc 
test (***P<0.001 for 30 mM glucose vs. 30 mM + CCCP or PBA). 
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Figure 3.3: PBA reduces lipid content in adipocytes over the time course of 
maturation.  (A) Adipocytes were matured in 5 mM or 30 mM glucose with or without 1 
mM PBA. Total protein was harvested and 30 μg protein separated by 1-D PAGE and 
probed with anti-PPARγ. (B) Adipocytes were treated with PBA on days 0-2 (C) and days 
0-8 of maturation. The triglyceride content was measured as described in the Materials 
and Methods. (D) The medium was collected after 2 days maturation and glucose 
content was measured as described in the Materials and Methods. The results are 
expressed as mean ± SD, n=4. Asterisks indicate statistical significance determined a One 
Way ANOVA (***p<0.001, **p<0.01 and *p<0.05 for 30 mM glucose vs. 30 mM glucose + 
PBA). A Kruskal-Wallis One Way Analysis of Variance on Ranks using Dunn’s method for 
data not normally distributed. 
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Figure 3.4: PBA reduces mitochondrial respiration in 30mM glucose. (A) To test 
whether or not PBA acted as a mitochondrial uncoupler, the Seahorse Extracellular Flux 
Analyzer (XF) 24 was used to measure effects on respiration when PBA is added acutely 
during the assay. FCCP (1.25 µM) served as a positive control and was only injected once 
(first arrow). PBA was injected into the wells on 3 occasions indicated by the arrows 
(black circles), at concentrations 1 mM, 5 mM and 10 mM PBA. SA was added to 
demonstrate the effects of a mild-uncoupler (gray circles) and was injected into the 
wells on 3 occasions indicated by the arrows at concentrations of 1 mM, 2 mM and 5 
mM. (B) Fold-change increase of the basal oxygen consumption rate after the drugs 
were added, ***P<0.001 for 5 mM glucose vs. FCCP and SA, n=5. (C) The respiratory 
profile of adipocytes cultured in 5 mM (blue circles) and 30 mM (red circles) glucose or 
30 mM with 1 mM (black triangles) or 5 mM (green triangles) PBA treatment on days 0-2 
of maturation was measured using the Seahorse XF24 as described in the Materials and 
Methods. Drugs were added at the indicated arrows to assess mitochondrial function. 
(D) Fold-change in basal respiration, ATP production, SRC, proton leak, and non-
mitochondrial respiration (NMR) were measured following the addition of oligomycin, 
FCCP and rotenone/antimycin A respectively. The results are expressed as a mean ± SD, 
n=5. Asterisks indicate statistical significance determined by a One Way ANOVA with a 
Tukey’s post-hoc test (***P<0.001 and *P<0.05 for 30 mM glucose vs. 30 mM glucose + 1 
mM or 5 mM PBA). A Kruskal-Wallis One Way Analysis of Variance on Ranks was 
performed when the data were not normally distributed. 
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Figure 3.5: PBA reduces ER stress and inhibits adipogenesis. (A) 3T3-L1 adipocytes 
matured in 5 mM glucose or 30 mM glucose +/- 1 mM or 5 mM PBA were harvested 
after 2 days of maturation. Protein (20 µg) was separated by 1-D PAGE and markers of 
adipogenesis, UPR/ER stress and mitochondrial metabolism were detected as described 
in the Materials and Methods. (B) DNA was isolated and mitochondrial content was 
measured as described in the Materials and Methods, n=6. A One Way ANOVA using a 
Tukey’s post-hoc test and a Kruskal-Wallis One Way Analysis of Variance on Ranks for 
data not normally distributed.
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Chapter IV 
Sodium Phenylbutyrate Treatment in db/db Mice 
4.1. Introduction 
The db/db mouse is a widely used model to study obesity and T2DM. There is a 
point mutation in the gene encoding the leptin receptor, rendering the receptor 
ineffective at binding its substrate hormone, leptin. Db/db mice have increased body 
weight at birth compared to heterozygotes, display hyperinsulinemia starting at 10-14 
days after birth and hyperglycemia by 4-8 weeks (59). We have previously used this 
mouse model to examine protein succination in diabetes and have demonstrated that 
db/db mice have increased levels of 2SC in the adipose tissue compared to control 
animals (29, 32).  
Previous experiments examining the effects of PBA in diabetic mice were 
conducted in the ob/ob mouse model and high-fat diet fed mice (25, 57). As we have 
previously used the db/db mouse, we were interested in determining whether or not 
PBA could reduce mitochondrial stress and protein succination in the adipose tissue of 
this model. We have shown that PDI is succinated on an active site residue and has 
reduced activity (unpublished results) which could promote ER stress by causing 
misfolded proteins to accumulate. Additionally, adiponectin is succinated on cysteine 
39, preventing the normal incorporation of the monomer into trimers and higher 
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molecular weight species that can be secreted from the cell (29). Therefore, we 
hypothesized that if PBA could reduce mitochondrial stress and succination in db/db 
mice, this may ultimately lower ER stress by preventing the succination of chaperone 
and/or ER processed proteins. Considering that insulin resistant and obese humans are 
known to have increased adipose tissue ER stress (48), we anticipated that our studies 
might demonstrate the therapeutic effects of PBA as a potential T2DM treatment. 
4.2. Results 
We administered PBA to 7 week old db/db mice for 8 weeks to assess whether or 
not the drug could limit adipose tissue dysfunction and reduce 2SC accumulation. The 
drug was administered in the drinking water of at a dosage of 1 mg/g body weight 
(BW)/day for the first 4 weeks and reduced to 0.5 mg/g BW/day for the remaining 4 
weeks. 
 As expected, Figure 4.1A demonstrates that db/db mice had significantly higher 
fasting blood glucose levels throughout the 8 weeks of the study compared to control 
mice (##P<0.01 ###P<0.001, Figure 4.1A). PBA had no effect on the FBG levels of control 
mice receiving PBA treatment (Figure 4.1A). In db/db mice, there was a trend for PBA 
treatment to lower FBG but this was only statistically significant at weeks 2 through 6 
(*P<0.05, **P<0.01, ***P<0.001 n=6, Figure 4.1A) due to the variability in FBG. 
Throughout the 8 week course of the study, db/db mice had a significantly higher body 
weight than control mice (###p<0.001, Figure 4.1B). PBA had no effect on the body 
weight of db/db mice whereas control mice receiving PBA treatment had a significantly 
higher body weight only after 7 weeks of treatment ($p<0.05, Figure 4.1A). 
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A regular chow diet was given ad libido. The amount of food consumed by the 
db/db mice was greater than the amount consumed by control mice, Figure 4.2A; 
although statistical analyses are not available as we housed 3 mice per cage. The db/db 
mice receiving PBA treatment tended to consume less food during the early weeks 1-5, 
~7 g/day when compared to the untreated db/db mice who consumed ~9 g/day (Figure 
4.2A). Food consumption was not different for any of the control mice throughout the 
study, with both groups consuming ~4-5 g/day. Water consumption was similar 
between control mice, ~0.2-0.3 mL/day/BW. The db/db (-)PBA mice consumed ~0.4-0.6 
mL/day/BW (Figure 4.2B) whereas the db/db (+)PBA mice consumed ~0.2-0.3 
mL/day/BW , similar to control mice (Figure 4.2B). The dosage of PBA in the water was 
reduced by 50% after 4 weeks treatment to ensure that the db/db (+)PBA mice were not 
drinking less water due to a dislike or ill effect of the drug. 
We assessed whole body composition of the mice at 14 weeks of age (after 7 
weeks of PBA treatment) using a Dual Energy X-ray Absorptiometry (DEXA) scan. Db/db 
mice had greater total lean mass, fat mass and % fat compared to control mice 
(###p<0.001, Figure 4.3A). There were no differences in lean mass, fat mass or % fat with 
or without PBA treatment in the db/db groups (Figure 4.3A). Interestingly, we 
documented decreased lean mass and increased % fat in the control mice that received 
PBA treatment compared to the untreated control mice (*p<0.05, Figure 4.3A). Upon 
sacrifice, we removed the epididymal fat pads from the animals and observed a 
significant increase in the mass of the fat pad from the db/db mice compared to control 
47 
 
mice (###p<0.001, Figure 4.3B), but no change was observed between db/db (-)PBA and 
db/db (+)PBA mice (Figure 4.3B). 
 To assess insulin sensitivity, we performed an insulin tolerance test after 7 weeks 
of PBA treatment. Insulin was injected intraperitoneally and blood glucose was 
measured over the course of 120 minutes. There was no difference in the response to 
insulin observed in the control mice with or without PBA treatment (Figure 4.4). There 
was a slight but significant reduction in the blood glucose levels of the db/db (+)PBA 
after 120 minutes compared to db/db (-)PBA (*p<0.05, Figure 4.4). 
 As PBA has been shown to reduce TG levels in ob/ob mice (57) we measured TG 
content in the serum of overnight fasted mice. TG levels ranged from 50-90 mg/dL in 
control mice and were elevated in db/db (-)PBA mice to ~150 mg/dL beginning at 9 
weeks of age (Figure 4.5A). Db/db (+)PBA mice had significantly reduced TG levels, ~50-
75 mg/dL, compared to db/db (-)PBA mice (*P<0.05, **P<0.01 and ***P<0.001, db/db 
(+)PBA vs. db/db (-)PBA, Figure 4.5A) throughout the course of PBA treatment. We then 
examined the TG content in the liver and observed ~5-fold increase in db/db (-)PBA 
versus control mice (###P<0.001 db/db, Figure 4.5B). Surprisingly, there was ~1.6-fold 
increase in TG levels in db/db (+)PBA compared to db/db (-)PBA mice (*P<0.05, Figure 
4.5B). 
 We have previously shown that PBA can reduce the levels of protein succination 
in 3T3-L1 adipocytes (Figure 3.2A). There is increased succination in epididymal adipose 
tissue of in db/db (-)PBA and db/db (+)PBA vs. control mice at 15 weeks of age (8 weeks 
post treatment) (Figure 4.6, anti-2SC). We did not observe a reduction in the levels of 
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succinated proteins in the db/db (+)PBA compared to the db/db (-)PBA mice (Figure 4.6). 
The adipogenic marker PPARγ was increased in db/db (-)PBA and db/db/+)PBA mice 
versus control and was unaltered by PBA treatment. PDI is moderately increased and 
there is a pronounced increase in CHOP protein levels in db/db mice versus control. This 
was unchanged by PBA treatment (Figure 4.6). Grp78 was decreased in db/db (-)PBA 
mice compared to control, and was increased db/db (+)PBA mice. Overall, PBA did not 
appear to have any significant effects on protein succination or the UPR/ER stress 
proteins in the epididymal adipose tissue of db/db mice. 
 Previous studies have shown that the liver has reduced TG levels, improved 
insulin signaling and decreased ER stress in ob/ob mice upon PBA treatment (57). In the 
liver tissue of the db/db (-)PBA and db/db (+)PBA mouse we detected increased PDI and 
CHOP levels but decreased Grp78 compared to control mice (Figure 4.7). Considering 
the significant increase in liver TG levels in db/db (+)PBA mice, we examined several 
proteins involved in fatty acid synthesis. The levels of phospho-acetyl-CoA carboxylase 
(p-ACC) were unchanged between control and db/db (-)PBA mice but the db/db (+)PBA 
mice had increased levels of p-ACC compared to both groups. Fatty acid synthase (FAS) 
was increased in db/db mice versus control (Figure 4.7) but no difference was observed 
in the protein levels with PBA treatment. 
4.3. Discussion 
PBA has been documented to reduce ER stress and blood glucose levels in 
several rodent models of obesity and diabetes (25, 57). We chose to study the effects of 
PBA in the db/db mouse model of diabetes as we have previously demonstrated 
49 
 
increased levels of protein succination in the suprarenal, subcutaneous and epididymal 
adipose tissue of these mice at 15 weeks age (32). In addition, activation of the UPR and 
ER stress have been documented in the liver and adipose tissue of db/db mice (60, 61). 
As we have shown that adiponectin (29) and PDI (unpublished results) are succinated in 
the adipose tissue of db/db mice, we hypothesized that PBA might reduce protein 
succination, thereby reducing ER stress and improving adipose homeostasis in db/db 
mice. 
We observed a significant reduction in blood glucose levels in db/db (+)PBA mice 
after 2 weeks of PBA treatment, lasting until week 6 (Figure 4.1A). While there was a 
trend for FBG to be lower in the db/db (+)PBA mice for the duration of the study, we 
reduced the concentration of PBA from 1 mg/g/day to 0.5 mg/g/day after 4 weeks of 
treatment over concerns regarding water consumption volumes. This change in dose 
may have contributed to the lack of a significant effect in FBG by weeks 7 and 8 of 
treatment.  There was a trend for mice treated with PBA to have increased body weight 
compared to untreated mice (Figure 4.1B) and this is a documented side effect of the 
drug in humans (62). There was a trend for less food to be consumed by db/db (+)PBA 
mice in the first 4 weeks of the study but the amount of food consumed/day after 8 
weeks was similar between the two groups, indicating that any trend for increased 
weight gain cannot be attributed to an increase in food consumption (Figure 4.2A). 
Water intake was monitored to ensure that the mice were receiving the correct drug 
dosage. We observed a significant reduction in the amount of water consumed in db/db 
(+)PBA mice during the first 4 weeks of the study compared to db/db (-)PBA mice (Figure 
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4.2B), therefore, we reduced the dosage of the drug appropriately to eliminate the 
possibility that any differences we observed were due to the effects of dehydration. 
Surprisingly, db/db (+)PBA mice consumed ~50% less water than db/db (-)PBA mice 
while control mice consumed the same amount of water throughout the 8 week 
treatment whether not PBA was present in their drinking water. As the drug 
concentration was adjusted weekly based on the body weight of the mice, by week 8 of 
treatment, the control (+)PBA mice were receiving a more concentrated solution of PBA 
water than the db/db (+)PBA mice. This suggests the reduced water consumption by the 
db/db (+)PBA mice was not related to taste, although PBA is known to have a bitter 
taste. 
We assessed whole body composition at 14 weeks of age (7 weeks treatment) 
and did not observe any changes in lean mass, fat mass or % fat in db/db mice with or 
without PBA treatment. Surprisingly, control (+)PBA mice had significantly higher % fat 
and decreased lean mass compared to control (-)PBA (Figure 4.5A). As we did not 
observe any differences in FBG, serum TG levels or food/water consumption between 
control mice with or without PBA treatment, we did not initially examine the epididymal 
or liver tissue in the treated controls. However, we are planning to analyze these tissues 
in the future as PBA may be having select effects on control mice. 
Non-alcoholic fatty liver disease is often associated with T2DM because 
increased serum TG levels and lipoprotein imbalances result in the uptake, synthesis and 
oxidation of free fatty acids by the liver (63). Although we observed a significant 
reduction in serum TG levels in db/db (+)PBA mice compared to db/db (-)PBA mice 
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(Figure 4.5A), there was an unexpected increase in TG levels in the liver tissue (Figure 
4.5B). We next examined the lipogenic protein levels to determine if lipogenesis was 
more active after PBA treatment, explaining the increase in TGs. It was found that 
regulation of the first step of fatty acid synthesis by p-ACC was unchanged between 
control and db/db (-)PBA mice but FAS was increased in db/db (-)PBA mice (Figure 4.7), 
suggesting that the fatty liver in db/db mice at 15 weeks is associated with up-regulation 
of FAS (64). We also found that p-ACC levels were increased in db/db (+)PBA mice 
compared to db/db (-)PBA mice, which suggests that there would have been less TG 
deposition as ACC catalyzes the first step in fatty acid biosynthesis (Figure 4.7). Further 
examination of other components of the lipogenic pathway may be necessary to 
determine what is contributing to increased triglycerides in liver. Additionally the 15 
week time point at which we looked at these enzymes may be too late and only offers 
limited insight into the regulation of TG accumulation which may have occurred at an 
earlier time point. (50). 
Our in vitro data in 3T3-L1 adipocytes demonstrated that 1 mM PBA treatment 
for 8 days can reduce the levels of protein succination in adipocytes matured in 30 mM 
glucose (Figure 3.2A). As a result, we had hypothesized that PBA would reduce protein 
succination and thereby alleviate ER stress in db/db mice. Protein succination was 
unaffected in the epididymal adipose tissue after 8 weeks in db/db (+)PBA mice (Figure 
4.6). We did not observe any difference in adipogenesis as noted by the master 
regulator of adipogenesis, PPARγ, in db/db (+)PBA. The protein levels of UPR or ER stress 
markers as indicated by PDI and CHOP were elevated in db/db mice but were 
52 
 
unchanged by PBA treatment (Figure 4.6). This is a surprising result as db/db mice have 
increased ER stress in the adipose tissue and that PBA was able to lower ER stress in and 
high fat diet fed mouse and ob/ob mouse (25, 57). 
 Overall, PBA reduced blood glucose levels and serum TGs in db/db mice, but 
increased the deposition of TGs in the liver – a negative metabolic outcome. The UPR 
and ER stress responses were unaffected by PBA treatment in the adipose tissue, which 
contrasts with the results of Ozcan et al. in ob/ob mice (57). However, this could be due 
to differences in the duration of the experiment, 8 weeks vs. 20 days, and/or age of 
mice at sacrifice, 15 weeks vs. 10-11 weeks (57). Our results thus far in the db/db model 
do not support the notion that PBA may be therapeutically useful in treating T2DM. 
Indeed our surprising finding that PBA increased deposition of TGs in the liver of db/db 
mice warrants further investigation of the negative effects of PBA. 
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Figure 4.1: Effects of PBA treatment effects on fasting blood glucose and body weight. 
Control and db/db mice were treated with or without 1 mg/g BW/day for the first 4 
weeks then reduced to 0.5 mg/g BW/day for the remaining 4 weeks of the study. (A) 
Fasting blood glucose was measured from the tail vein after an overnight fast. (B) Body 
weights were taken once per week in the morning after an overnight fast. Data are 
representative of n=5-6 mice expressed as means ± S.D. Data were subjected to a Two 
Way Repeated Measures ANOVA (One Factor Repetition) to test for significance 
($P<0.05 for control (-)PBA vs. control (+)PBA and ###P<0.001 for Db/db vs. control).  
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Figure 4.2: Effects of PBA treatment of food consumption and water intake. Food and 
water consumption were given ad libido to the mice. Control and db/db mice were 
treated with PBA in the drinking water at a dosage of 1 mg/g BW/day for the first 4 
weeks then reduced to 0.5 mg/g BW/day for the remaining 4 weeks of the study. (A) 
Food consumption and (B) water intake were measured bi-weekly. Data are 
representative of n=2-3 mice per cage. 
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Figure 4.3: Effects of PBA treatment on body composition. (A) Mice were subjected to 
a DEXA scan at 14 weeks of age (7 weeks +/- PBA treatment) to assess fat and lean body 
mass. (B) At the time of sacrifice, epididymal fat pads were removed and weighed. Data 
are representative of n=5-6 mice expressed as means ± S.D. Data were subjected to a 
One-way ANOVA using Tukey’s post hoc test to test for statistical significance 
(###P<0.001 for db/db vs. control).  
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Figure 4.4: PBA Treatment improves insulin sensitivity. At 14 weeks of age (7 weeks -/+ 
PBA treatment) mice were fasted for 4 hours and then given an injection of 2U insulin 
intraperitoneally. Blood glucose was measured from tail vein bleeds over the course of 
120 minutes. Data are representative of n=5-6 mice, expressed as means ± S.D. Data 
were subjected to Two Way Repeated Measures ANOVA (One Factor Repetition) to test 
for statistical significance (*P<0.05 for db/db (-)PBA vs. db/db (+)PBA). 
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Figure 4.5 PBA reduces serum triglyceride levels but increases liver triglyceride levels. 
Mice were fasted weekly for 12-16 hours overnight and tail vein blood was collected. (A) 
Triglyceride levels in serum of overnight fasted mice. (B) A portion of the liver was used 
for triglyceride analysis and the results are expressed relative to the protein content. 
Data are representative of n=5-6 mice, expressed as means ± S.D. Asterisks indicate 
statistical significance as determined by a (A) Two Way repeated measure ANOVA and 
(B) a One Way Tukey’s post hoc test (**P<0.01 and ***P<0.001 for db/db (-)PBA vs. db/db 
(+)PBA and #P<0.05, ##P<0.01 and ###P<0.001 for db/db (-)PBA vs. control). 
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Figure 4.6 PBA does not reduce ER Stress in epididymal adipose tissue of db/db mice. 
Analysis of succinated proteins and ER stress markers in epididymal adipose tissue of 
control and db/db mice at 15 weeks of age (8 weeks +/- PBA treatment). Protein was 
separted by 1-D PAGE and 100 μg was used for the detection of 2SC using polyclonal 
anti-2SC antibody and 60 μg was used for the detection of Grp78, PDI (UPR) and CHOP 
(ER stress) proteins. Molecular weights are shown in kDa (left) and β-Tubulin is shown to 
demonstrate protein loading. 
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Figure 4.7 PBA does not alter the ER stress response but increases the inhibition of 
ACC.  Analysis of UPR and ER stress proteins in control and db/db mice at 15 weeks of 
age Proteins, 40 μg, was separated by 1-D PAGE for the detection of Grp78, PDI (UPR) 
and CHOP (ER stress) and lipogenesis markers. Molecular weights are shown in kDa (left) 
and a Coomassie is shown to demonstrate protein loading.
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Chapter V 
The Turnover of Succinated Proteins 
5.1. Introduction 
 In the cell there are two protein degradation pathways for the removal of 
damaged or unwanted proteins, the ubiquitin proteasome system (UPS) and the 
lysosomal degradation system (also referred to as autophagy) (Figures 5.1 & 5.2) (65, 
66). Protein degradation is a regulated process that responds to remove damaged 
proteins and organelles or to provide amino acids in response to changes in the cellular 
nutrient status (67). 
 The UPS is primarily responsible for the degradation of cytosolic, ER, nuclear, and 
short-lived proteins. Turnover occurs in a sequential process by which an 8.5 kDa 
ubiquitin protein is attached to the protein to be degraded on a lysine residue (67). 
Subsequent ubiquitin molecules can be attached to internal residues on ubiquitin itself, 
forming an ubiquitin chain that signals the protein to be degraded by the proteasome 
(Figure 5.1) (65, 68). However, ubiquitin can also be a signal for certain proteins to be 
selectively degraded by autophagy, and it appears that the internal lysine residue of 
ubiquitin that serves as an anchor point for additional ubiquitin molecules is the key 
player in determining the proteins fate (67). The 26S proteasome is a large ~2.5 MDa 
ATP-dependent complex consisting of the 20s catalytic particle (CP) and the 19s 
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regulatory particle (RP). The CP is a barrel-shaped structure in which the proteolytic 
activity is sequestered and has limited access to proteins destined to be degraded as a 
result of gating by other residues. The proteolytic core contains three proteases with 
different specificities; acidic residues (caspase-like), basic residues (trypsin-like) and 
hydrophobic residues (chymotrypsin-like) (Figure 5.1) (68). 
 Autophagic degradation has a much broader proteolytic role than proteasomal 
degradation in that whole organelles such as mitochondria (mitophagy) or peroxisomes 
(pexophagy) can be degraded in addition to individual proteins (67). In the first step of 
autophagy a double-membraned structure known as a phagophore surrounds items to 
be degraded. As the phagophore is forming, more ‘cargo’ can be added and the 
membrane can continue to grow until it becomes an enclosed double-membrane 
structure known as an autophagosome, a process that is mediated by several 
autophagy-related proteins (Atgs) (Figure 5.2) (69). In the committed step of autophagy, 
microtubule-associated protein light chain 3 (LC3-I) is converted to LC3-II via lipidation 
with phosphatidylethanolamine and is attached to the autophagosome. The cargo-
loaded vesicle can then fuse with the lysosome, which contains hydrolases capable of 
protein degradation (67). The primary hydrolases present in the lysosomes of 
adipocytes are cathepsin B (cysteine protease) and cathepsin D (aspartic protease) (70).  
 We have identified ~40 succinated proteins and the majority of these are 
cytosolic proteins (34). Additionally, we have previously demonstrated that 2SC is 
produced endogenously in rats and is excreted in the urine (31), suggesting that there is 
an intracellular mechanism that can facilitate the removal of succinated proteins. Due to 
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the stability of the thioether bond and that there are no known enzymes that can cleave 
the thioether bond, we hypothesized that succinated cytosolic proteins were 
predominantly being degraded in the adipocyte by the proteasome. We therefore 
investigated the turnover of succinated proteins in the 3T3-L1 adipocyte cultured in high 
glucose conditions versus normal glucose to determine if (1) succinated proteins were 
being turned over and (2) the mechanism of degradation of succinated proteins.  
5.2. Results 
The accumulation of succinated proteins in 3T3-L1 adipocytes in 30 mM glucose 
is significantly increased at days 4-6 of maturation in association with increased 
intracellular concentrations of fumarate (31). As noted in Figure 5.3A, there is an 
increase in the levels of 2SC in adipocytes matured in 30 mM glucose compared to 5 
mM glucose for 8 days. The reaction of fumarate with cysteine is a non-enzymatic 
process, therefore, we next sought to determine if stable succinated proteins could be 
removed from within the cell. When adipocytes are matured in 30 mM glucose for 4 
days and then switched to 5 mM glucose for the remaining 4 days of maturation, the 
levels of 2SC no longer accumulate and are similar to the levels observed in adipocytes 
that matured in 5 mM glucose for 8 days (Figure 5.3A). This indicated that there was 
intracellular turnover of the succinated proteins that had accumulated up until 4 days. 
We then sought to determine specifically when the levels of 2SC began to decline after 
removing the high glucose stimulus. As observed in Figure 5.3B, the levels of 2SC began 
to decline as early as 1 day after 30 mM glucose removal. In particular there is a greater 
reduction in band intensity for proteins with a mass ~30-37 kDa and ~75-100 kDa (Figure 
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5.3B). If the 30 mM glucose is replaced with 5 mM glucose for longer time periods, from 
1 day up until 4 days, the extent of protein succination is further reduced (Figure 5.3B). 
 To determine the intracellular mechanism by which the succinated proteins were 
being degraded, we next inhibited either the proteasome or the lysosome. MG132 (a 
proteasome inhibitor) or chloroquine (a lysosomal inhibitor) were used to attenuate 
protein degradation. The adipocytes were matured for 4 days in 30 mM glucose and 
then switched to 5 mM glucose -/+ MG132 or chloroquine for the remaining 4 days of 
maturation. Figure 5.4A&B confirms that 2SC is increased in adipocytes matured for 8 
days in 30 mM and that this is decreased when the high glucose stimulus is removed 
after 4 days and replaced with 5 mM glucose for the remaining 4 days (lanes 4-6 vs. 7-9). 
For the adipocytes that were switched from 30 mM to 5 mM glucose and 
simultaneously treated with 17.5 µM MG132 (lanes 10-12, Figure 5.4A), there was no 
accumulation of succinated proteins (Figure 5.4A), suggesting the proteasomal 
inhibition does not prevent the degradation of succinated proteins. However, in a 
parallel experiment where the adipocytes were switched from 30 mM to 5 mM glucose 
and treated with 25 µM chloroquine, succinated proteins did accumulate (lanes 10-12, 
Figure 5.4B). This indicated that the lysosome appears to be primarily responsible for 
the degradation of succinated proteins. Inhibition of the lysosome was confirmed by the 
pronounced increase in LC3-I and LC3-II in chloroquine treated adipocytes compared to 
the untreated adipocytes (Figure 5.4B). 
Considering that we had established that succinated proteins were being 
degraded, we next sought to quantify the release of free 2SC from the adipocyte using 
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gas chromatography-mass spectrometry (GC/MS). We measured the basal levels of 2SC 
in the Dulbecco’s Modified Eagles Medium (DMEM) and 10% fetal bovine serum (FBS) to 
ensure that the 2SC we detected was produced by the adipocyte (rather than measure 
any endogenous 2SC in the cell culture reagents). In DMEM, we detected ~0.03 mmol 
2SC/mol lysine and in DMEM supplemented with 10% FBS we detected ~0.05 mmol 
2SC/mol lysine (data not shown). It has previously been shown that the levels of 
fumarate in the cell culture medium increase throughout adipocyte maturation in 25 
mM glucose (71). We determined the amount of 2SC present on FBS proteins 
(predominantly albumin) when adipocytes were matured in 5 mM or 30 mM glucose in 
order to ensure that any free 2SC detected in the maturation medium was being 
released from the cells and was not derived from the released fumarate modifying FBS 
proteins (Figure 5.5). In order to do this we separated the serum protein from the free 
amino acids/peptides released from the cell by trichloroacetic acid precipitation of the 
protein in the medium. When the serum protein was analyzed (after it was hydrolyzed 
to release free 2SC) there was no difference in the levels of 2SC in the maturation 
medium of adipocytes matured in 5 mM or 30 mM glucose on days 4-6, (Figure 5.5). 
This indicated that any changes in 2SC could not be attributed to fumarate reacting with 
serum proteins in the medium.  
Next, we sought to quantify how much 2SC was being synthesized in and 
released from the adipocyte itself. Adipocytes were matured in 5 mM or 30 mM glucose 
for 8 days, or 30 mM glucose for 4 days then 5 mM glucose for the remaining 4 days -/+ 
chloroquine. As indicated in Figure 5.6A, there was an ~1.9-fold increase in 2SC in 30 
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mM glucose vs. 5 mM glucose in the cell lysate after 8 days of maturation (***p<0.001, 
Figure 5.6A). In adipocytes that were switched to normal glucose after 4 days 
maturation, there was a significant reduction in 2SC in the cell lysate compared to 
adipocytes matured in 30 mM glucose for 8 days (###p<0.001, Figure 5.6A). When the 
adipocytes were treated with chloroquine concomitant with the switch to 5 mM glucose 
the levels of 2SC were significantly elevated compared to 5 mM glucose (***p<0.001, 
Figure 5.6A). We then examined when 2SC was being released from the cells into the 
culture medium. Analysis of the culture medium from early maturation days 2-4 
revealed a ~1.5-fold increase in 2SC in the medium of adipocytes matured in 30 mM 
glucose vs. 5 mM glucose (***p<0.001, Figure 5.6B). As before, on maturation day 4 a 
subset of adipocytes were switched from 30 mM to 5 mM glucose for the remainder of 
maturation and treated with or without chloroquine. The culture medium from days 4-6 
contained ~1.5-fold more 2SC in 30 mM glucose than 5 mM glucose (***p<0.001, Figure 
5.6C). Surprisingly, there was no increase in the 2SC in the culture medium of adipocytes 
that had been switched from 30 mM to 5 mM glucose (Figure 5.6C), as might be 
expected if the 2SC was being degraded intracellularly and released from the cell. The 
levels of 2SC in the culture medium of adipocytes that had been treated with 
chloroquine were similar to 2SC levels observed in 5 mM glucose (Figure 5.6C), 
consistent with chloroquine preventing degradation and release. Culture medium from 
late maturation days 6-8 had a similar ~1.3-fold increase in 2SC in adipocytes matured in 
high glucose (**p<0.01 and ***p<0.001 Figure 5.6D). 2SC did not increase in the culture 
medium of adipocytes that had undergone the switch from high to normal glucose on 
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days 6-8 (Figure 5.6D). Unexpectedly, the adipocytes that had been treated with 
chloroquine had a ~1.6-fold increase in 2SC in the culture medium on days 6-8 vs. 
adipocytes matured in normal glucose for 8 days (***p<0.001, Figure 5.6D). 
The above measurements demonstrated that free 2SC was detectable in the 
culture medium. However, the hydrolysis step in preparation for GC/MS analysis did not 
allow us to differentiate whether the 2SC was released as a free modified cysteine or as 
part of a small peptide incorporating the 2SC. We examined the culture medium of 
adipocytes matured in normal or high glucose on days 4-6. The samples were divided 
into two equal parts after removal of the serum proteins, one part being subjected to 
hydrolysis to determine the total amount of 2SC, and the other not hydrolyzed 
representing the amount of free 2SC released from the adipocyte. As observed in Figure 
5.7, there was ~0.039 mmol 2SC/mol lysine total in the culture medium while there was 
0.008 mmol 2SC/mol lysine detected as free 2SC in the culture medium in adipocytes 
matured in 5 mM glucose. In adipocytes matured in 30 mM glucose there was 0.09 
mmol 2SC/mol lysine total in the culture medium while 0.04 mmol 2SC/mol lysine is 
liberated as free 2SC. The difference in the total 2SC and that detected as free 2SC 
(detected in the absence of peptide hydrolysis) represents the fraction that is peptide 
bound, demonstrating that 2SC is released both as a free amino acid and as part of a 
peptide. 
5.3. Discussion 
The formation of S-(2-Succino)cysteine (2SC) is an irreversible chemical 
modification as the reaction of fumarate with cysteine forms a thioether bond, which is 
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very stable, and there are no known enzymes that can cleave this bond. Protein 
succination is increased in 3T3-L1 adipocytes that have been matured 30 mM glucose vs. 
5 mM glucose (Figure 5.3, 5.4 and 5.6) and in the adipose tissue of ob/ob and db/db 
mice (32). We were interested in determining if and how succinated proteins were being 
degraded in the adipocyte as we had previously shown that rats excreted 2SC in their 
urine (31), indicating turnover occurred in vivo. We observed that adipocytes matured in 
high glucose for 4 days that were then switched to normal glucose for the remaining 4 
days of maturation had levels of succination similar to cells that had matured in normal 
glucose for 8 days, indicating that accumulated succinated proteins can be degraded 
intracelluarly (Figure 5.3A). We used the proteasomal inhibitor, MG132, and the 
lysosomal inhibitor, chloroquine, to determine which intracellular protein degradation 
pathway was responsible for the turnover of 2SC. In the presence of MG132, succinated 
proteins did not accumulate (Figure 5.4A) suggesting the proteasome was not involved. 
In contrast, when the adipocytes were switched to normal glucose in the presence of 
chloroquine, turnover of succinated proteins was prevented (Figure 5.2B), indicating 
that the lysosome was responsible for the degradation of succinated proteins. This 
conflicted with our original hypothesis, as we predicted the proteasome would be 
responsible for degrading succinated proteins considering that we had primarily 
identified succinated cytosolic and ER proteins (34). However, this data is interesting 
considering that autophagy is responsible for removal of damaged organelles such as 
mitochondria (mitophagy). It will be important in future studies to look at the turnover 
of specific organelle containing fractions by the lysosome. 
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 The analysis of the 2SC content in the cell lysates and culture medium by GC/MS 
(Figure 5.6A-D) indicated that levels of succinated proteins in adipocytes matured in 30 
mM glucose were always significantly increased compared to 5 mM glucose. We were 
able to detect 2SC in the culture medium at all time points from days 2-8 indicating the 
turnover of some fraction of succinated proteins appears to be a continuous process in 
adipocytes matured in both 30 mM and 5 mM glucose. We also demonstrated that 2SC 
is released from the adipocyte both as a free amino acid and as part of a peptide, as 
indicated by the differences in the levels of 2SC that were detected when the samples 
were prepared -/+ hydrolysis to release the 2SC (Figure 5.7). 
When adipocytes are matured in high glucose and then switched to normal 
glucose, the levels of succinated proteins are significantly reduced compared to 
adipocytes that matured in high glucose for 8 days (Figure 5.6A). Analysis of the 2SC 
content in the culture medium of these adipocytes from days 4-6 and days 6-8 did not 
show an increase in the levels of 2SC released from the cell, which was unexpected as 
the intracellular levels of 2SC had been reduced close to normal levels. During the 
workup process of the cell lysate, the proteins are precipitated with 10% TCA and free 
amino acids and peptides remain the supernatant and this was not analyzed for the cell 
lysates. It is possible that the ‘missing’ 2SC had been degraded into peptides and amino 
acids, but had not yet been released into the medium by the cell and therefore was not 
detected. 
 In adipocytes that had been treated with chloroquine, the degradation of 2SC 
was prevented as indicated by the sustained levels of 2SC even when the high glucose 
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stimulus is removed (Figure 5.4B & 5.6A). The analysis of the culture medium on days 4-
6 did not show a significant increase in the amount of 2SC compared to 5 mM glucose, 
indicating that the degradation of 2SC modified proteins had been prevented. However, 
the culture medium from days 6-8 indicated a significant increase in the levels of 2SC 
(Figure 5.6D) which was not expected when the lysosome is inhibited. We suspect that 
prolonged inhibition of the lysosome may alternatively up-regulate proteasomal activity, 
thereby degrading proteins that may not normally be degraded by that pathway and 
contributing to the detected increase in 2SC (72).  
 It is worth noting that although adipocytes matured in 5 mM glucose could 
produce more 2SC had they of been matured in 30 mM glucose (Figure 5.6A), there is 
still degradation of the basal levels of 2SC present in the adipocytes (Figure 5.6B-D), 
demonstrating that autophagy is constantly occurring in the adipocyte. We have 
preliminary data suggesting that autophagy is impaired in adipocytes matured in 30 mM 
glucose which may explain adipocyte dysfunction when in high glucose. Mitophagy has 
been shown to be an important process involved in the differentiation of 3T3-L1 
fibroblasts into 3T3-L1 adipocytes as atg5-/- and atg7-/-deficient MEFs have reduced 
adipogenesis efficiency as noted by defective lipid droplet formation and compromised 
TG synthesis (73). However, as our adipocytes proceed through differentiation normally 
in both 5 mM and 30 mM glucose (as indicated by the PPARγ and adiponectin 
production (Figure 2.3A)) autophagy is unlikely impaired at this stage. Interestingly, in 
3T3-L1 adipocytes matured in high glucose, autophagy was suppressed and mRNA levels 
of pro-inflammatory cytokines were elevated (74) as were the levels of secreted 
70 
 
cytokines (Figure 2.4), suggesting that impaired autophagy is associated with adipocyte 
dysfunction. 
 In conclusion, we have shown that 2SC modified proteins are degraded through 
autophagy in the adipocyte. This is in contrast to our original hypothesis that the 
proteasome would be involved. We are currently studying the degradation of 2SC in 
different cellular compartments to examine if the location of succinated proteins within 
the cell determines the degradation pathway. In addition, we are interested in 
determining whether or not adipocytes matured in high glucose are undergoing 
autophagy at a different rate to adipocytes matured in 5 mM glucose. Therefore future 
studies will examine autophagic flux within the cell to determine the kinetics of 
succinated protein turnover. 
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Figure 5.1. Schematic of protein degradation by the ubiquitin proteasome system. 
Misfolded or aggregated proteins are ubiquitinated in an ATP-dependent manner. The 
ubiquitinated protein is recognized by the proteasome which then degrades that protein 
into its constituent parts and recycles the ubuiquitin molecules for marking other 
proteins for degradation (65). 
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Figure 5.2 Induction of autophagy and lysosomal degradation. Schematic of autophagic 
degradation from phagophore formation to autophagolysosome formation. Atgs assist 
in the formation of the autophagic vesicle and Atg3 and Atg7 mediate lipidation of LC3-I, 
forming LC3-II which is incorporated in the autophagosomal membrane (66). 
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Figure 5.3. Time course of the turnover of succinated proteins. (A) Adipocytes were 
matured in 5 mM or 30 mM glucose for 8 days. A subset of adipocytes was matured in 
30 mM glucose for 4 days then switched to 5 mM glucose for the remaining 4 days. 
Protein (40 µg) was separated by 1-D PAGE and succinated proteins were detected using 
a polyclonal anti-2SC antibody (B) Adipocytes were matured in 5 mM or 30 mM glucose 
for 8 days. A subset of adipocytes were switched from 30 mM glucose and replaced with 
5 mM glucose for 4, 3, 2, or 1 remaining days of maturation (30→5). Protein (30 µg) was 
separated by 1-D PAGE and 2SC was detected using a polyclonal anti-2SC antibody to 
detect the presence of succinated proteins. Molecular weight (MW) markers (kDa) are 
shown as a reference for the range in MW of succinated proteins. 
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Figure 5.4. Turnover of succinated proteins. Adipocytes were matured in 5 mM or 30 
mM glucose for 8 days. A subset of adipocytes were matured in 30 mM glucose for 4 
days and then switched to 5 mM glucose for the remaining 4 days of maturation 
(30→5). They were then treated with or without (A) 17.5 µM MG132 or (B) 25 µM 
chloroquine. Protein (A) 30 µg and (B) 40 µg was separated by 1-D PAGE and detection 
of 2SC was performed using a polyclonal anti-2SC antibody. Western blotting for LC3 
was assessed to confirm inhibition of lysosomal degradation. MW markers are shown in 
kDa and β-Tubulin is shown to demonstrate equal protein loading. 
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Figure 5.5. Modification of serum proteins by succination. 3T3-L1 adipocytes were 
matured in 5 mM or 30 mM glucose. The maturation medium was collected from the 
adipocytes on maturation days 4-6 and serum protein was TCA precipitated and 
analyzed by GC/MS for 2SC and lysine content. The 2SC content was normalized to the 
lysine content of the sample. Data are representative of n=4-5 measurements expressed 
as means ± S.D. Data were tested for statistical significance using an unpaired Student t 
test. 
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Figure 5.6. GC/MS analysis of 2SC content in adipocyte cell lysate and culture medium. 
Adipocytes were matured in 5 mM or 30 mM glucose for 8 days. A subset of adipocytes 
was matured in 30 mM glucose for 4 days and then switched to 5 mM glucose for the 
remaining 4 days (30→5) and treated with or without chloroquine (CQ). (A) On day 8, 
the cells were harvested and the levels of intracellular succinated proteins was 
determined in the cell lysate by GC/MS. Medium was collected from days (B) 2-4, (C) 4-6 
and (D) 6- 8 of maturation and analyzed by GC/MS for 2SC content. Data are 
representative of n=5 measurements expressed as means ± S.D. Statistical significance 
was determined using a One Way ANOVA and  Tukey’s post hoc test (*P<0.05 **P<0.01 
and ***P<0.001 for 30 mM glucose or 30 to 5mM ±CQ vs. 5 mM glucose and ###P<0.001 
for 30 mM vs. 30 to 5 mM. Gray bars ( 5 mM), black bars (30 mM), striped bars (30 mM 
to 5 mM), and checkered bars (30 mM to 5 mM + CQ)). 
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Figure 5.7: Release of 2SC as an amino acid or in a peptide. 3T3-L1 adipocytes were 
matured in 5 mM or 30 mM glucose. The medium from days 4-6 of maturation was 
analyzed for total and free 2SC content by GC/MS. Data are representative of n=3 
measurements expressed as means ± S.D. Asterisks indicate statistical significance as 
determined by a paired Student t test (*P<0.05 and ***P<0.001. Black bars (total 2SC in 
5 mM glucose), light gray striped (free 2SC in 5 mM glucose), gray bars (total 2SC in 30 
mM glucose), and gray striped bars (free 2SC in 30 mM glucose)).
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Chapter VI 
Future Directions 
We are interested in continuing our investigation into the role of ER stress in the 
development of T2DM and plan to examine human adipose tissue and determine if 
protein succination is increased in T2DM subjects. We are also interested in alternative 
chemical agents/uncouplers that may reduce protein succination as they may be 
therapeutically beneficial in treating T2DM.  
Our results on the turnover of succinated proteins by autophagy were 
unexpected and intriguing. Consequently, we are interested in the role of autophagy in 
adipocyte pathology during T2DM. Our preliminary data suggests that autophagy may 
be dysfunctional in adipocytes matured in high glucose and interestingly, if the 
adipocytes are switched to normal glucose there is restoration of autophagic function. 
We have identified cathepsin B as a protein that is succinated at its active site, Cys-108 
(34), so it will be of interest to determine if the activity of Cathepsin B is reduced and 
whether or not this affects lysosomal function in the adipocyte. We are also interested 
in another autophagy protein, Atg7, as the active site also contains a cysteine residue 
(75), and this may as also affect the rate of autophagy if succinated. Atg7 is one of the 
proteins that lipidates LC3-I, committing the autophagosome to fuse with the lysosome.  
Lastly, as we have identified 2SC as a novel protein modification that is increased 
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in diabetes, were are interested in continuing to investigate the biochemical mechanism 
by which this leads to adipocyte dysfunction. We have identified over 40 succinated 
proteins (34) and we still have to examine the significance of many of these identified 
sites and to determine if and how the function of these 2SC modified proteins is 
affected in T2DM. 
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Chapter VII 
Methods 
Materials. Unless otherwise noted, all chemicals were purchased from Sigma Aldrich (St. 
Louis, MO). Preparation of 2SC antibody was prepared by Eurogentec (Fremont, CA) 
Sodium phenylbutyrate (PBA) was from Enzo Life Sciences (Farmingdale, NY) for in vitro 
studies and Scandinavian Formulas Inc. (Sellersville, PA) for in vivo studies. 
Polyvinylidene fluoride (PVDF) was purchased from GE Healthcare (Farifield, CT). L-
glycine, sodium dodecyl sulfate (SDS), sodium salicylate (SA), and Tween-20 were 
purchased from Fisher Scientific (Waltham, MA).  For in vitro studies insulin was 
purchased from Bio Ab Chem (Ladson, SC). For in vivo studies insulin was purchased 
from Sigma Aldrich (St. Louis, MO). For in vitro studies glucose oxidase was from 
Invitrogen (Grand Island, NY) and for in vivo studies glucose oxidase was from Raichem 
(San Marcos, CA). Criterion™TGX™ Precast Gels were from Bio-Rad (Hercules, CA). The 
CyQuant® assay was from Invitrogen (Grand Island, NY). All materials for the Seahorse 
XF24 were purchased from Seahorse Bioscience (North Billerica, MA) except pyruvate, 
glucose, insulin, and mitochondrial inhibitors. 
Animal Models. Male C57BL/6 mice were purchased from Jackson Laboratories (Bar 
Harbor, ME). Mice were obtained at 5-6 weeks of age and allowed to acclimate 1-2 
weeks with unrestricted access to food and water before experimental manipulations 
began. 
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PBA was administered in the drinking water at a dosage of 1 mg/g BW/day for 
the first 3 weeks and was reduced to 0.5 mg/g BW/day for the remaining 4 weeks of the 
study. Animals were sacrificed at 15 weeks of age. Blood glucose measurements were 
performed weekly after an overnight fast by collecting tail vain blood using a Bayer 
(Whippanny, NJ) Countour® blood glucose meter for control animals and the glucose 
oxidase assay for db/db mice. 
  Water and food consumption was measured biweekly. All animal handling and 
experiments were conducted according to the guidelines of the University of South 
Carolina Institutional Animal Care and Use Committee. Animals were sacrificed using 
CO2 asphyxiation and epididymal adipose tissue was removed and rinsed in PBS with 
protease inhibitors and frozen on dry ice. Livers were removed and immediately frozen 
on dry ice.  
Body Composition. Body composition was measured at 14 weeks using a Dual Energy X-
ray Absorptiometry scan under isoflurane anesthesia, measuring fat and lean content.  
Insulin Tolerance Test. Insulin tolerance tests were performed at 14 weeks of age on all 
mice. The mice were fasted starting the morning of the test for 4.5 hours. Insulin was 
injected intraperitoneally, 2 U. Blood was collected by tail vein at time 0, 15, 30, 60, 90, 
and 120 minutes after injection of insulin. Blood glucose was measured in control 
animals using a Bayer (Whippanny, NJ) Countour® blood glucose meter. In db/db mice, 
the glucose oxidase assay was used to measure serum blood glucose levels. 
Protein Extraction from Adipose Tissue. Adipose tissue was added to 2.5 mL ice-cold 
radio immunoprecipitation assay buffer (RIPA) buffer and sonicated 3 times for 12-15 
82 
 
seconds each. The tissue sat on ice for 30 minutes and was then centrifuged at 2800 g 
for 10 minutes at 4 oC. A pellet, infranatant and supernatant were then visible. The 
infranatant, up to 1.5 mL was then collected using a needle and syringe. Acetone, 9X 
volume, was then added to the samples, vortexed, then let sit on ice for 10 min. The 
samples were then centrifuged at 2800 g for 10 minutes at 4oC. The acetone was 
decanted and the samples let air dry for 10 min on ice. The samples were then 
resuspended in 0.5 – 1 mL of radio RIPA buffer and sonicated 3 times for 10 seconds 
each. The samples were then centrifuged at 15000 rpm for 10 min at 4 oC yielding an 
infranatant and a fat layer. The infranatant was collected and the protein concentration 
was determined using the Lowry assay. 
Protein Extraction from Liver Tissue. Liver tissue was added to 2 mL ice-cold RIPA buffer 
and sonicated 2 times for 10-15 seconds each and was then centrifuged at 2800 g for 10 
minutes at 4 oC. A pellet, infranatant and supernatant were then visible. The infranatant, 
up to 1.5 mL was then collected using a needle and syringe. Acetone, 9X volume, was 
then added to the samples, vortexed then let sit on ice for 10 min. The samples were 
then centrifuged at 2800 g for 10 minutes at 4oC. The acetone was decanted and the 
samples let air dry for 10 min on ice. The samples were then resuspended in 1 mL of 
RIPA buffer and sonicated 3 times for 10 seconds each. The samples were then 
centrifuged at 15000 rpm for 10 min at 4 oC yielding an infranatant and a fat layer. The 
infranatant was collected and the protein concentration was determined using the 
Lowry assay. 
Triglyceride Extraction from Liver Tissue. Liver tissue was added to ice-cold PBS with 
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protease inhibitors and sonicated 3 times for 10 seconds each. 300 μL of sample was 
then extracted using 8:4 chloroform:methanol. The samples were vortexed, then let sit 
on ice for 10 min followed by centrifugation at 2000 g for 10 min at 4 oC. Three layers 
formed with the protein interface dividing the infranatant and supernatant. The 
infranatant was collected and was dried under air. The samples were resuspended in 5% 
BSA and triglyceride concentration was determined using InfinityTM Triglycerides assay 
kit (Thermo Fisher Scientific, Waltham, MA), according to the manufacturer’s 
instructions. 
Cell Culture. 3T3-L1 murine fibroblast were purchased from American Type Culture 
Collection (Manassas, VA) and maintained up to 8 passages in DMEM containing 5 mM 
glucose, 10% Bovine Calf Serum (Thermo Scientific), 1% penicillin/streptomycin (CellGro) 
at 37oC with 5% CO2 and 95% humidity. Medium was changed every 2 days. At 70-80% 
confluence cells were trypsinized (Thermo Scientific), neutralized with excess medium 
and collected by centrifugation at 1000 g for 5 min at 25oC. The cells were then 
resuspended in medium for a new passage. 
3T3-L1 fibroblasts were seeded at densities of 10,000, 50,000, and 100,000 
cells/well for 24-well, 6-well plates and 10 cm2 petri dishes respectively. 3T3-L1 
fibroblasts were induced to differentiate when the fibroblast reached 24 hours post-
confluence (~3-4 days) in DMEM with 10% Fetal Bovine Serum (Atlanta Biologicals), 1% 
penicillin/streptomycin, insulin (10 μg/mL), dexamethasone (0.3 μM), 3-isobutyl-1-
methylxanthine (0.5 mM) and 30 mM glucose for 3 days. At day 0, differentiation 
medium was removed, cells were washed with PBS and maturation medium containing 
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5 mM/0.3 nM or 30 mM/3 nM glucose/insulin was applied. The medium was changed 
every 2 days and the adipocytes were matured for up to 8 days. Cells cultured in 5 mM 
glucose were supplemented with 5mM glucose daily and several hours prior to protein 
harvest to maintain glucose levels. 
Measurement of triglycerides, glucose, and inflammatory markers in 3T3-L1 
adipocytes. Triglyceride content was measured in 10 µl aliquots of cell lysates using the 
InfinityTM Triglycerides assay kit (Thermo Fisher Scientific, Waltham, MA), according to 
the manufacturer’s instructions. Glucose concentration was measured in phenol red 
free medium using the Amplex® Red Glucose/Glucose Oxidase Assay kit (Invitrogen, 
Grand Island, NY). The media on 3T3-L1 adipocytes was replaced with serum-free 
DMEM for 18 hrs. Pro-inflammatory cytokines in the conditioned media were analyzed 
by ELISA according to the manufacturer’s instructions (mouse Obesity ELISA, Signosis, 
Santa Clara, CA). 
DNA isolation and mitochondrial content analysis. Cell lysates were collected in 500 µL 
PBS, centrifuged at 2000 rpm for 5 min to yield a pellet which was resuspended in 350 
µL DNA lysis buffer (10 mM Tris-HCl, pH7 7.5, 400 mM NaCl, 2.5 mM EDTA , and 0.1% 
SDS), 50 µL of 50 mg/mL proteinase K and heated at 55°C overnight. The tubes were 
inverted to dissolve any remaining solid then extracted in a 1:1 ratio of lysis 
buffer:saturated phenol, pH 7.9. The samples were then centrifuged at 15000 rpm for 5 
min, the supernatant was collected and extracted in a 1:1 ratio, 
supernatant:phenol/chloroform/isoamyl alcohol (25:24:1), pH 7.9 then centrifuged at 
15000 rpm for 5 min. The supernatant was collected and the DNA was precipitated with 
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350 µL 100% ethanol and 35 µL of 3 M sodium acetate, pH 5.2, and collected by 
centrifugation at 15000 rpm for 2 min. The DNA pellet was washed with 70% ethanol, 
dried, then resuspended in 100 µL water. The samples were stored at -20°C until PCR. 
Quantitative real-time PCR analysis was carried out in 25 μl reactions consisting 
of 2x SYBR green PCR buffer (AmpliTaq Gold DNA Polymerase, Buffer, dNTP mix, MgCl2) 
(Applied Biosystems, Foster City, CA, USA), 0.150 μg DNA, DI water, and 60 nM of each  
primer. PCR was run with the DNA sample with Cytochrome B Forward, 5′ - ATT CCT TCA 
TGT CGG ACG AG −3′; Cytochrome B Reverse, 5′ - ACT GAG AAG CCC CCT CAA AT - 3′, 
GAPDH Forward, 5′ - TTG GGT TGT ACA TCC AAG CA - 3′; GAPDH Reverse, 5′ - CAA GAA 
ACA GGG GAG CTG AG - 3′. Samples were analyzed on an ABI 7300 Sequence Detection 
System. Reactions were incubated for 2 minutes at 50°C and 10 minutes at 95°C, 
followed by 40 cycles consisting of a 15 sec denaturing step at 95°C and 1 min 
annealing/extending step at 60°C. Data were analyzed by ABI software (Applied 
Biosystems, Foster City, CA, USA) using the cycle threshold (CT), which is the cycle 
number at which the fluorescence emission is midway between detection and 
saturation of the reaction. The 2-Δ CT method was used to determine changes in gene 
expression between Cytochrome B with GAPDH CT as the correction factor. 
Protein Extraction from Cells. All samples and reagents were kept on ice during protein 
harvest. The cells were washed 3 times with phosphate buffered saline (PBS). The cells 
were collected in RIPA buffer and pulse sonicated at 2 watts for 3 intervals of 3 seconds. 
Acetone was then added in 9 times the volume, the samples were vortexed then let 
precipitate on ice for 10 minutes. The protein was collected by centrifugation at 2000 g 
86 
 
for 10 minutes at 4oC yielding a white to pale yellow protein pellet. The supernatant was 
decanted and the pellet let air dry for 10 minutes on ice. The protein was resuspended 
in RIPA buffer and pulse sonicated for 3 intervals of 3 seconds. The samples were stored 
at -70oC until further analysis. 
Western Immunoblotting. Samples were prepared using 25-40 µg for cell lysates and 
40-100 μg for mice tissue with the addition of 5-7 μL 4X Laemmli loading buffer. The 
samples were then boiled at 95oC, flash centrifuged then loaded on 7.5%, 12% or 18% 
gels and electrophoresed at 200 V for 60 min. The protein was transferred to a PVDF 
membrane in transfer buffer at 250 mA for 100 min or 40 mA at 4 oC. The membrane 
was ponceau stained then blocked in 5% non-fat milk or 5% bovine serum albumin (BSA) 
according to the manufacturer’s instructions. Membranes were probed using primary 
polyclonal anti-2SC. Antibodies for ACC, p-ACC, calreticulin, cleaved caspase-3, eIF2α, p-
eIF2α, Ero1-Lα, FAS, fumarase, LC3, and succinate dehydrogenase were from Cell 
Signaling. Adiponectin was from R&D Systems. CHOP was from Thermo Scientific. 
NDUSF4 was from AbCam. β-tubulin, Grp78 and PDI were from Santa Cruz. Pierce® ECL 2 
Western Blotting Substrate or Amersham™ ECL™ Prime Western Blotting Detection 
Reagent (GE Healthcare) was used and followed by detection of chemiluminescence 
using photographic film (Denville Scientific, Metuchen, NJ). Image J software (NIH) was 
used to quantify band intensity by densitometry. 
GC/MS Analysis of 2SC. 3T3-L1 adipocytes were matured as described in cell culture. 
The cell culture medium from adipocytes was collected on days 4, 6 and 8 of maturation 
and frozen at -70°C until further analysis. Adipocytes were harvested for protein after 8 
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days of maturation as described in protein harvest. DMEM and culture medium were 
extracted in an 8:4:3 chloroform/methanol/water ratio. The samples were vortexed and 
let precipitate on ice for 10 min followed by centrifugation at 2000 g for 10 min at 4oC. 
Three layers formed, with the protein interface (albumin) separating the organic 
(bottom) and water/methanol (top) layer. The water/methanol layer was collected and 
the contents were dried overnight on a speedvac. The samples were resuspended in 600 
μL water and sonicated, extraction was re-performed and the samples were dried 
overnight.  
Cell lysates were extracted in a 1:1 ratio with 20% (w/v) trichloroacetic acid, 
vortexed, let precipitate on ice for 10 min then centrifuged at 2500 g for 5 min at 4oC 
yielding a pellet and supernatant. The pellet was resuspended in 500 μL 10% (w/v) TCA 
and let precipitate on ice for 10 min then centrifuged at 2500 g for 5 min at 4oC yielding 
a protein pellet. 
To each sample 75 nmol D8-Lys, 0.375 nmol heavy labeled-2SC and 1 mL 12 N 
HCl was added, followed by overnight hydrolysis at 110oC. The samples were then dried 
overnight on the speedvac. The samples were resuspended in 1 mL of 1% trifluoroacetic 
acid (TFA), sonicated, and passed over a C-18 SepPak column pre-wet with 2 mL 
methanol and 2 mL 1% TFA. The analyte was eluted with 20% methanol/1% TFA and 
dried overnight on the speedvac. To each sample was then added methanolic HCl, 
followed by vortexing, heating for 45 min at 65°C then dried under air. Trifluroacetic 
acid anhydride was then added, 1 mL, to each sample, and let sit for 1 hr at room 
temperature, then dried under air for ~15 min. Dichloromethane, 200 µL, was then 
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added to the samples before being centrifuged at 10,000 g for 5 min at 25oC. The 
samples were then concentrated under air. 
Samples were analyzed by multiple reaction monitoring GC-MS/MS on a TSQ 
7000 (Thermo-Finnigan, Waltham, MA). The injection port was maintained at 200 °C, 
and the temperature program was 90 °C hold for 2 min, 10 °C/min from 90 to 140 °C, 3 
°C/min to 220 °C, 15 °C/min to 300 °C, then hold at 300 °C for 5 min. The parent and 
daughter ion pairs monitored were: lysine m /z  180 > 69, d8 -lysine, m /z  188 > 69; 2SC, 
m /z  284 > 242, U-13 C3 ,15 N-2SC m /z  288 > 246. Quantification of analytes in protein 
samples was performed by isotope dilution mass spectrometry based on standard 
curves constructed from mixtures of known amounts of heavy labeled and natural 
abundance standard. The amounts of all analytes were normalized to the lysine content 
of the sample. 
Seahorse Extracellular Flux Analyzer 24. 3T3-L1 murine fibroblast were seeded 10,000 
cells/well in a 100 μL volume on XF24 V7 microculture plates coated with 0.2% gelatin 
(Sigma, porcine skin, Type A, Batch # 014K0077). The next day, 150 μL of medium was 
added to the cells. Fibroblasts grew for 3 days followed by differentiation and 2 days of 
maturation. 
The night before the assay, an XF calibrant cartridge was hydrated overnight in 
XF calibrant, pH 7.4 at 37oC with 0% CO2. The day of the assay, the medium was 
removed, the adipocytes were washed with 1 mL of XF Assay Buffer, pH 7.4, followed by 
application of 600 μL XF Assay medium, pH 7.4, supplemented with 1% 
penicillin/streptomycin, 1 mM sodium pyruvate, 5 mM/0.3 nM or 30 mM/3 nM 
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glucose/insulin, and incubation for 60-90 min at 37oC with 0% CO2. Injections were 
added in a 1:9 volume in the following order: blank, oligomycin (5 µg/mL), carbonyl 
cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) (1.25 µM), rotenone/antimycin A 
(3 µM/4 µM). Assay conditions involved a mixing (3 min), a wait (2 min), and a measure 
(3 min) after addition of the blank, oligomycin and rotenone/antimycin A (3 µM/4 µM) 
and PBA. For FCCP, the conditions were a mixing (2 min) followed by a measurement (2 
min). For SA, the conditions were mixing (4 min), wait (2 min), followed by a 
measurement (2 min). 
Following the assay the cells were washed with PBS and stored at -70oC. The DNA 
content was quantified using the CyQuant® assay according to the manufacture’s 
protocol. 
Data Analysis. All graphs were generated in Sigmaplot 11. Statistical analyses of the 
data were performed on SigmaStat software (Sigmaplot 11, San Jose, CA). All data were 
plotted as means ± SD. An unpaired Student t test was used to test for statistical 
differences between two sets of data, except in Figure 5.7 where an unpaired t test was 
used. A One Way ANOVA using Tukey’s post hoc test was used when comparing 3 or 
more sets of data. A Kruskal-Wallis One Way Analysis of Variance on Ranks was used for 
data not normally distributed. FBG and serum TGs were tested for statistical differences 
using a Two Way Repeated Measures ANOVA (One Factor Repetition). Differences were 
considered statistically significant at *p<0.05, **p<0.01 and ***p<0.001. 
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Appendix A 
Buffer Preparations 
 
RIPA Buffer 
The buffer was prepared in 200 mL stocks containing 50 mM Tris-HCl pH 8, 150 mM 
NaCl, 1% Triton-X, 0.5% sodium deoxycholate, 0.1% SDS, and 2 mM EDTA. On day of use, 
2 mM sodium orthovanadate, 2 mM sodium fluoride and protease inhibitor (1:1000) 
was added to the buffer. The buffer was stored at 4oC. 
 
Running Buffer 
One liter of 10x stock was prepared containing 250 mM Tris-HCl, 1920 mM glycine and 
10% (SDS). 
 
Transfer Buffer 
One liter of 10X stock was prepared containing 250 mM Tris-HCl, 1920 mM glycine. 
Methanol was added at 20% for transfer process. 
 
Wash Buffer 
One liter of 10X stock was prepared containing 200 mM Tris-HCl, pH 7.4. Tween-20 was 
added at 0.05% to 1X was buffer. 
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Appendix B: 
Lowry Assay 
Pipette the specific amounts of reagents into the microplate in the order listed. All 
samples are prepared in duplicates. 
 
Table B.1: Preparation of BSA standard curve for the Lowry assay. 
Probe 
BSA 
(µL) 
H20 
(µL) 
Copper 
Reagent 
(µL) Incubation 
Folin-
Ciocolateu 
(µL) Incubation 
Blank 0 20 20 
 
60   
1 1 19 20   60   
2 2 18 20   60   
3 3 17 20   60   
4 4 16 20   60   
5 8 12 20   60   
6 10 10 20   60   
7 20 0 20   60   
Sample 5 15 20   60   
  
Stock BSA 
Dissolve 50 mg BSA (Bovine Serum Albumin) in 10 mL deionized water=5 mg/mL 
stock/working solution 
 
Working Solutions: Dilute 400 µL of 5 mg/mL stock in 600 µL water=2 mg/mL solution 
 
Table B.2: Preparation of copper reagent for Lowry assay. 
Stock Solution Working Solution 
Copper Sulfate 1% (w:v) 100 µL 
Sodium Tartrate 2% (w:v) 100 µL 
Sodium Carbonate 10% (w:v) in 0.5 M NaOH 2 mL 
 
Folin-Ciocolateu Phenol Reagent: Purchased as a 2 N stock solution. For working 
solution at 500 µL of stock solution to 5.5 mL of water 
Read absorbance at 660nm.
2
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7
o
C
 
3
0
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in
u
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 3
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o
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Appendix C 
Western Blotting 
 
Gel Electrophoresis 
 
1. After determining the protein content from the Lowry assay, 30-40 µg of protein was 
dissolved in water and 5 µL of Laemmli loading buffer was added. 
 
2. Boil the samples for 15 min at 95°C then flash centrifuge. 
 
3. Remove tape and comb from Bio-Rad pre cast Criterion gel and place in cassette. 
 
4. Fill the cassette tank and gel with Tris/Glycine/SDS running buffer. 
 
5. Load the samples into their individual lanes and 8 µL of marker into your lane of 
choice. 
 
6. Run the gel at 200 V for 60 min. 
 
Wet Transfer 
 
1. Remove the gel from the pre-cast and cut to size 
 
2. Soak the gel in Tris/Glycine/Methanol transfer buffer for 15 min. 
 
3. Charge the PVDF membrane for ~30 sec in methanol. Soak the 2 pieces of blotting 
paper, 2 sponges, and the membrane in Tris/Glycine/methanol for 15 min. 
 
4. Assemble the transfer apparatus, starting with the black side first. Keep all materials 
soaking in transfer buffer during the assembly. 
 
5. Place the sponge flat on the black side, followed by a piece of blotting paper. Next, 
place the gel on top followed by the PVDF membrane. Roll out any air bubbles between 
the gel and membrane using a roller. Finally, put the remaining piece of blotting paper 
on top of the membrane and the sponge on top.
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6. Assemble the apparatus and transfer at 250 mA for 100 min or 40 mA for at least 12 
hrs. 
 
7. Remove the membrane from the apparatus and wash 3 times with nanopure water. 
8. Place the membrane in ponceau stain for 5 min then wash with nanopure water to 
visualize the bands. Inspect the membrane for equal loading and where bubbles formed 
during the transfer process. Wash the ponceau stain off the membrane with Tris-HCl 
wash buffer. 
 
9. Block the membrane in 5% non-fat dry milk or 5% BSA for at least 1hr. 
 
Immunostaining for 2SC 
 
1. Prepare 1% milk by diluting the 5% milk 1:4 in Tris-HCl wash buffer. 
 
2. Add 2SC antibody to the milk in a 1:5000 dilution. Incubate for at least 1 hr on the 
rocker. 
 
3. Pour off the antibody and wash the membrane 3 times in wash buffer for 5 min each. 
 
4. Add secondary antibody anti-rabbit to 1% milk, 1:15000 dilution and incubate for 1hr 
at room temperature. 
 
5. Pour off the milk and was the membrane 3 times for 5 min each in wash buffer.  
 
Developing 
 
1. Prepare ECL solution by adding solution B to solution A and in a 1:40 dilution. 
 
2. Add the ECL to the membrane and incubate for 5 min. Place the membrane in the 
cassette and cover with plastic wrap. 
 
3. In the dark room, place a piece of X-ray film over the membrane then develop. 
Inspect the film after it has developed and adjust the exposure times accordingly. 
 
Buffers 
 
1. Stock Running Buffer: 10X SDS – 30.3 g Tris base, 144 g glycine and 10 g SDS 
dissolved to 1 L water 
- Working solution=100mL  of 10X stock diluted to 1L water 
2. Stock Transfer Buffer: 10X transfer – 30.3 g Tris base and 144 g glycine dissolved to 1 
L water 
- Working solution=150 mL of 10X stock and 300 mL of methanol diluted to 1 L 
water 
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3. Stock Wash Buffer: 10X Wash – 24.4 g Tris base dissolved to 1 L water, pH 7.4 
- Working solution=100 mL of 10X stock and 500 µL Tween-20 diluted to 1 L water 
 
